Molecular	O
regulation	O
of	O
the	O
human	B-DNA
IL-3	I-DNA
gene	I-DNA
:	O
inducible	O
T	O
cell-restricted	O
expression	O
requires	O
intact	O
AP-1	B-DNA
and	I-DNA
Elf-1	I-DNA
nuclear	I-DNA
protein	I-DNA
binding	I-DNA
sites	I-DNA
.	O

Interleukin	B-protein
3	I-protein
(	O
IL-3	B-protein
)	O
is	O
a	O
hematopoietic	B-protein
stem-cell	I-protein
growth	I-protein
and	I-protein
differentiation	I-protein
factor	I-protein
that	O
is	O
expressed	O
solely	O
in	O
activated	O
T	B-cell_type
and	I-cell_type
NK	I-cell_type
cells	I-cell_type
.	O

Studies	O
to	O
date	O
have	O
identified	O
elements	O
5	O
'	O
to	O
the	O
IL-3	B-DNA
coding	I-DNA
sequences	I-DNA
that	O
regulate	O
its	O
transcription	O
,	O
but	O
the	O
sequences	O
that	O
confer	O
T	O
cell-specific	O
expression	O
remain	O
to	O
be	O
clearly	O
defined	O
.	O

We	O
have	O
now	O
identified	O
DNA	B-DNA
sequences	I-DNA
that	O
are	O
required	O
for	O
T	O
cell-restricted	O
IL-3	B-DNA
gene	I-DNA
transcription	O
.	O

A	O
series	O
of	O
transient	O
transfections	O
performed	O
with	O
human	B-DNA
IL-3-chloramphenicol	I-DNA
acetyltransferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
reporter	I-DNA
plasmids	I-DNA
in	O
T	B-cell_type
and	I-cell_type
non-T	I-cell_type
cells	I-cell_type
revealed	O
that	O
a	O
plasmid	B-DNA
containing	O
319	O
bp	O
of	O
5	B-DNA
'	I-DNA
flanking	I-DNA
sequences	I-DNA
was	O
active	O
exclusively	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Deletion	O
analysis	O
revealed	O
that	O
T	B-cell_type
cell	I-cell_type
specificity	O
was	O
conferred	O
by	O
a	O
49-bp	B-DNA
fragment	I-DNA
(	O
bp	B-DNA
-319	I-DNA
to	I-DNA
-270	I-DNA
)	O
that	O
included	O
a	O
potential	B-DNA
binding	I-DNA
site	I-DNA
for	O
AP-1	B-protein
transcription	I-protein
factors	I-protein
6	O
bp	O
upstream	O
of	O
a	O
binding	B-DNA
site	I-DNA
for	I-DNA
Elf-1	I-DNA
,	O
a	O
member	O
of	O
the	O
Ets	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

DNaseI	B-protein
footprint	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
analyses	O
performed	O
with	O
MLA-144	B-cell_line
T	I-cell_line
cell	I-cell_line
nuclear	O
extracts	O
demonstrated	O
that	O
this	O
49-bp	B-DNA
region	I-DNA
contains	O
a	O
nuclear	B-DNA
protein	I-DNA
binding	I-DNA
region	I-DNA
that	O
includes	O
consensus	B-DNA
AP-1	I-DNA
and	I-DNA
Elf-1	I-DNA
binding	I-DNA
sites	I-DNA
.	O

In	O
addition	O
,	O
extracts	O
prepared	O
from	O
purified	B-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
contained	O
proteins	O
that	O
bound	O
to	O
synthetic	O
oligonucleotides	O
corresponding	O
to	O
the	O
AP-1	B-DNA
and	I-DNA
Elf-1	I-DNA
binding	I-DNA
sites	I-DNA
.	O

In	O
vitro-transcribed	O
and	O
-translated	O
Elf-1	B-protein
protein	I-protein
bound	O
specifically	O
to	O
the	O
Elf-1	B-DNA
site	I-DNA
,	O
and	O
Elf-1	O
antisera	O
competed	O
and	O
super	O
shifted	O
nuclear	O
protein	O
complexes	O
present	O
in	O
MLA-144	B-cell_line
nuclear	O
extracts	O
.	O

Moreover	O
,	O
addition	O
of	O
anti-Jun	O
family	O
antiserum	O
in	O
electrophoretic	O
mobility	O
shift	O
assay	O
reactions	O
completely	O
blocked	O
formation	O
of	O
the	O
AP-1-related	B-protein
complexes	I-protein
.	O

Transient	O
transfection	O
studies	O
in	O
MLA-144	B-cell_line
T	I-cell_line
cells	I-cell_line
revealed	O
that	O
constructs	O
containing	O
mutations	O
in	O
the	O
AP-1	B-DNA
site	I-DNA
almost	O
completely	O
abolished	O
CAT	O
activity	O
while	O
mutation	O
of	O
the	O
Elf-1	B-DNA
site	I-DNA
or	O
the	O
NF-IL-3	B-DNA
site	I-DNA
,	O
a	O
previously	O
described	O
nuclear	B-DNA
protein	I-DNA
binding	I-DNA
site	I-DNA
(	O
bp.	B-DNA
-155	I-DNA
to	I-DNA
-148	I-DNA
)	O
in	O
the	O
IL-3	B-DNA
promoter	I-DNA
,	O
reduced	O
CAT	O
activity	O
to	O
<	O
25	O
%	O
of	O
the	O
activity	O
given	O
by	O
wild-type	O
constructs	O
.	O

We	O
conclude	O
that	O
expression	O
of	O
the	O
human	B-DNA
IL-3	I-DNA
gene	I-DNA
requires	O
the	O
AP-1	B-DNA
and	I-DNA
Elf-1	I-DNA
binding	I-DNA
sites	I-DNA
;	O
however	O
,	O
unlike	O
other	O
previously	O
characterized	O
cytokine	B-DNA
genes	I-DNA
such	O
as	O
IL-2	B-protein
,	O
the	O
AP-1	B-protein
and	I-protein
Elf-1	I-protein
factors	I-protein
can	O
bind	O
independently	O
in	O
the	O
IL-3	B-DNA
gene	I-DNA
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
:	NULL
Inducible	NULL
T	NULL
Cell-Restricted	NULL
Expression	NULL
Requires	NULL
Intact	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
Nuclear	NULL
Protein	NULL
Binding	NULL
Sites	NULL
By	NULL
Lisa	NULL
R.	NULL
Gottschalk	NULL
,	NULL
*	NULL
Diane	NULL
M.	NULL
Giannola	NULL
,	NULL
t	NULL
and	NULL
Stephen	NULL
G.	NULL
Emersont	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60637	NULL
;	NULL
and	NULL
the	NULL
tDepartment	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
48109	NULL
Summary	NULL
Interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
a	NULL
hematopoietic	NULL
stem-cell	NULL
growth	NULL
and	NULL
differentiation	NULL
factor	NULL
that	NULL
is	NULL
expressed	NULL
solely	NULL
in	NULL
activated	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

Studies	NULL
to	NULL
date	NULL
have	NULL
identified	NULL
elements	NULL
5	NULL
'	NULL
to	NULL
the	NULL
IL-3	NULL
coding	NULL
sequences	NULL
that	NULL
regulate	NULL
its	NULL
transcription	NULL
,	NULL
but	NULL
the	NULL
sequences	NULL
that	NULL
confer	NULL
T	NULL
cell-specific	NULL
expression	NULL
remain	NULL
to	NULL
be	NULL
clearly	NULL
defined	NULL
.	NULL

We	NULL
have	NULL
now	NULL
identified	NULL
DNA	NULL
sequences	NULL
that	NULL
are	NULL
required	NULL
for	NULL
T	NULL
cell-restricted	NULL
IL-3	NULL
gene	NULL
transcription	NULL
.	NULL

A	NULL
series	NULL
of	NULL
transient	NULL
transfections	NULL
performed	NULL
with	NULL
human	NULL
IL-3-chloremphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
plasmids	NULL
in	NULL
T	NULL
and	NULL
non-T	NULL
cells	NULL
revealed	NULL
that	NULL
a	NULL
plasmid	NULL
containing	NULL
319	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
was	NULL
active	NULL
exclusively	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Deletion	NULL
analysis	NULL
revealed	NULL
that	NULL
T	NULL
cell	NULL
specificity	NULL
was	NULL
conferred	NULL
by	NULL
a	NULL
49-bp	NULL
fragment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-270	NULL
)	NULL
that	NULL
included	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
AP-1	NULL
transcription	NULL
factors	NULL
6	NULL
bp	NULL
upstream	NULL
of	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Elf-1	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
DNasel	NULL
footprint	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
analyses	NULL
performed	NULL
with	NULL
MLA-144	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
demonstrated	NULL
that	NULL
this	NULL
49-bp	NULL
region	NULL
contains	NULL
a	NULL
nuclear	NULL
protein	NULL
binding	NULL
region	NULL
that	NULL
includes	NULL
consensus	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
extracts	NULL
prepared	NULL
from	NULL
purified	NULL
human	NULL
T	NULL
cells	NULL
contained	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
vitro-transcribed	NULL
and	NULL
translated	NULL
Elf-1	NULL
protein	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
Elf-1	NULL
site	NULL
,	NULL
and	NULL
Elf-1	NULL
antisera	NULL
competed	NULL
and	NULL
super	NULL
shifted	NULL
nuclear	NULL
protein	NULL
complexes	NULL
present	NULL
in	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Moreover	NULL
,	NULL
addition	NULL
of	NULL
anti-Jun	NULL
family	NULL
antiserum	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
reactions	NULL
completely	NULL
blocked	NULL
formation	NULL
of	NULL
the	NULL
AP-1-related	NULL
complexes	NULL
.	NULL

Transient	NULL
transfection	NULL
studies	NULL
in	NULL
MLA-144	NULL
T	NULL
cells	NULL
revealed	NULL
that	NULL
constructs	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
AP-1	NULL
site	NULL
almost	NULL
completely	NULL
abolished	NULL
CAT	NULL
activity	NULL
while	NULL
mutation	NULL
of	NULL
the	NULL
EIf-1	NULL
site	NULL
or	NULL
the	NULL
NF-IL-3	NULL
site	NULL
,	NULL
a	NULL
previously	NULL
described	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
bp	NULL
-155	NULL
to	NULL
-148	NULL
)	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
reduced	NULL
CAT	NULL
activity	NULL
to	NULL
<	NULL
25	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
wild-type	NULL
constructs	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
requires	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
;	NULL
however	NULL
,	NULL
unlike	NULL
other	NULL
previously	NULL
characterized	NULL
cytokine	NULL
genes	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
factors	NULL
can	NULL
bind	NULL
independently	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
exact	NULL
DNA	NULL
composition	NULL
of	NULL
these	NULL
sites	NULL
,	NULL
flanking	NULL
DNA	NULL
sequences	NULL
,	NULL
and	NULL
the	NULL
distance	NULL
between	NULL
the	NULL
AP-1	NULL
and	NULL
Ets	NULL
family	NULL
binding	NULL
sites	NULL
determine	NULL
the	NULL
fine	NULL
specificity	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
and	NULL
the	NULL
resulting	NULL
inducible	NULL
,	NULL
cell-restricted	NULL
expression	NULL
of	NULL
a	NULL
group	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

he	NULL
growth	NULL
factor	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
is	NULL
a	NULL
major	NULL
regu-	NULL
lator	NULL
of	NULL
hematopoiesis	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-3	NULL
is	NULL
particularly	NULL
interesting	NULL
because	NULL
IL-3	NULL
is	NULL
secreted	NULL
from	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
and	NULL
primarily	NULL
acts	NULL
on	NULL
both	NULL
early	NULL
stem	NULL
cells	NULL
and	NULL
hematopoietic	NULL
cells	NULL
committed	NULL
to	NULL
distinct	NULL
lineages	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Alone	NULL
,	NULL
IL-3	NULL
stimulates	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
bone	NULL
marrow	NULL
precursor	NULL
cells	NULL
to	NULL
produce	NULL
macrophages	NULL
,	NULL
eosinophils	NULL
,	NULL
and	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
other	NULL
growth	NULL
factors	NULL
,	NULL
IL-3	NULL
influences	NULL
the	NULL
development	NULL
of	NULL
erythrocytes	NULL
,	NULL
megakaryocytes	NULL
,	NULL
and	NULL
neu-trophils	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-3	NULL
supports	NULL
the	NULL
growth	NULL
of	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
bone	NULL
marrow	NULL
cultures	NULL
and	NULL
enhances	NULL
retrovirus-mediated	NULL
gene	NULL
transfer	NULL
into	NULL
bone	NULL
marrow	NULL
stem	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
lymphokine	NULL
forms	NULL
a	NULL
bridge	NULL
between	NULL
the	NULL
immune	NULL
system	NULL
and	NULL
homeostasis	NULL
in	NULL
non-immune	NULL
tissues	NULL
.	NULL

IL-3	NULL
is	NULL
distinguished	NULL
from	NULL
other	NULL
growth	NULL
factors	NULL
by	NULL
its	NULL
restricted	NULL
cellular	NULL
expression	NULL
and	NULL
mode	NULL
of	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
only	NULL
activated	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
8-10	NULL
)	NULL
produce	NULL
IL-3	NULL
,	NULL
whereas	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
GM-CSF	NULL
and	NULL
G-CSF	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
agent	NULL
of	NULL
activation	NULL
is	NULL
critical	NULL
to	NULL
optimal	NULL
IL-3	NULL
gene	NULL
induction	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
cytokines	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
lymphotoxin	NULL
(	NULL
LT	NULL
)	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
GM-CSF	NULL
,	NULL
incubation	NULL
of	NULL
T	NULL
1681	NULL
__	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/93/11/1681/12	NULL
$	NULL
2.00	NULL
Volume	NULL
178	NULL
November	NULL
1993	NULL
1681-1692	NULL
cells	NULL
with	NULL
the	NULL
lectin	NULL
lymphotoxin	NULL
(	NULL
LT	NULL
)	NULL
PHA	NULL
alone	NULL
,	NULL
or	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
,	NULL
PMA	NULL
,	NULL
with	NULL
and	NULL
without	NULL
anti-CD28	NULL
fails	NULL
to	NULL
induce	NULL
substantial	NULL
IL-3	NULL
expression	NULL
(	NULL
8	NULL
,	NULL
14	NULL
)	NULL
.	NULL

To	NULL
induce	NULL
high-level	NULL
IL-3	NULL
gene	NULL
expression	NULL
,	NULL
T	NULL
cells	NULL
must	NULL
be	NULL
activated	NULL
via	NULL
the	NULL
TCR/CD3	NULL
pathway	NULL
or	NULL
with	NULL
agents	NULL
that	NULL
mimic	NULL
this	NULL
pathway	NULL
(	NULL
PMA	NULL
and	NULL
ionomycin	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Although	NULL
much	NULL
is	NULL
known	NULL
regarding	NULL
the	NULL
biological	NULL
activities	NULL
and	NULL
requirements	NULL
for	NULL
induction	NULL
of	NULL
IL-3	NULL
in	NULL
vitro	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
understood	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

The	NULL
genes	NULL
for	NULL
both	NULL
the	NULL
murine	NULL
and	NULL
the	NULL
human	NULL
homo-logue	NULL
of	NULL
IL-3	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
and	NULL
comparison	NULL
between	NULL
the	NULL
two	NULL
sequences	NULL
reveals	NULL
a	NULL
low	NULL
level	NULL
of	NULL
sequence	NULL
identity	NULL
except	NULL
for	NULL
some	NULL
short	NULL
regions	NULL
of	NULL
sequence	NULL
homology	NULL
in	NULL
the	NULL
5°	NULL
and	NULL
3	NULL
'	NULL
flanking	NULL
regions	NULL
.	NULL

Two	NULL
recent	NULL
reports	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-3	NULL
mRNA	NULL
accumulation	NULL
is	NULL
controlled	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
studies	NULL
describing	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IL-3	NULL
promoter	NULL
consists	NULL
of	NULL
two	NULL
activating	NULL
regions	NULL
separated	NULL
by	NULL
an	NULL
inhibitory	NULL
region	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

The	NULL
3	NULL
'	NULL
activating	NULL
region	NULL
contains	NULL
two	NULL
motifs	NULL
common	NULL
to	NULL
many	NULL
lymphokine	NULL
promoters	NULL
,	NULL
the	NULL
CK-1	NULL
and	NULL
CK-2	NULL
elements	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
3	NULL
'	NULL
activating	NULL
region	NULL
contains	NULL
a	NULL
sequence	NULL
similar	NULL
to	NULL
the	NULL
Oct-1	NULL
motif	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
,	NULL
NF-IL-3	NULL
,	NULL
and	NULL
an	NULL
element	NULL
immediately	NULL
3	NULL
'	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
a	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

These	NULL
latter	NULL
two	NULL
motifs	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
ACT	NULL
-1	NULL
(	NULL
21	NULL
)	NULL
may	NULL
be	NULL
important	NULL
for	NULL
IL-3	NULL
activation	NULL
.	NULL

The	NULL
inhibitory	NULL
region	NULL
includes	NULL
a	NULL
sequence	NULL
referred	NULL
to	NULL
as	NULL
NIP	NULL
that	NULL
binds	NULL
a	NULL
nuclear	NULL
protein	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
!	NULL

(	NULL
19	NULL
)	NULL
thought	NULL
to	NULL
restrict	NULL
IL-3	NULL
expression	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
as	NULL
the	NULL
NIP	NULL
site	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
functionally	NULL
inhibitory	NULL
in	NULL
activated	NULL
ML	NULL
A-144	NULL
gibbon	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
site	NULL
alone	NULL
can	NULL
not	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
restriction	NULL
of	NULL
IL-3	NULL
expression	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
number	NULL
of	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
inducible	NULL
T	NULL
cell-related	NULL
genes	NULL
contain	NULL
an	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
an	NULL
Ets	NULL
family	NULL
nuclear	NULL
protooncogene	NULL
binding	NULL
site	NULL
,	NULL
and	NULL
these	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
gene	NULL
expression	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
5	NULL
activation	NULL
region	NULL
of	NULL
IL-3	NULL
contains	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
AP-1	NULL
motif	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
phorbol	NULL
ester	NULL
inducibility	NULL
upon	NULL
heterologous	NULL
reporter	NULL
genes	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
regulate	NULL
activation	NULL
of	NULL
many	NULL
inducible	NULL
genes	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
human	NULL
IL-3	NULL
promoter	NULL
contains	NULL
a	NULL
consensus	NULL
Ets	NULL
family	NULL
binding	NULL
site	NULL
6	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
AP-1	NULL
motif	NULL
.	NULL

Thus	NULL
,	NULL
given	NULL
the	NULL
distinct	NULL
lineage	NULL
restricted	NULL
and	NULL
TCR-inducible	NULL
pattern	NULL
of	NULL
IL-3	NULL
gene	NULL
expression	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
address	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
the	NULL
role	NULL
of	NULL
these	NULL
sites	NULL
in	NULL
regulating	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
AP-1	NULL
and	NULL
an	NULL
Ets	NULL
family	NULL
binding	NULL
site	NULL
,	NULL
Elf-1	NULL
,	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
49-bp	NULL
fragment	NULL
containing	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
contributes	NULL
to	NULL
T	NULL
cell-restricted	NULL
expression	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
re	NULL
1	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

1682	NULL
quirement	NULL
of	NULL
AP-1	NULL
factor	NULL
complex	NULL
formation	NULL
for	NULL
NFAT	NULL
binding	NULL
activity	NULL
seen	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
27	NULL
)	NULL
,	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
sites	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
can	NULL
bind	NULL
their	NULL
respective	NULL
proteins	NULL
or	NULL
protein	NULL
complexes	NULL
independently	NULL
.	NULL

We	NULL
also	NULL
confirm	NULL
that	NULL
the	NULL
NFE-IL-3	NULL
site	NULL
is	NULL
required	NULL
for	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
the	NULL
basis	NULL
for	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
T	NULL
cell	NULL
IL-3	NULL
gene	NULL
regulation	NULL
and	NULL
its	NULL
role	NULL
in	NULL
the	NULL
cellular	NULL
link	NULL
between	NULL
the	NULL
immune	NULL
system	NULL
and	NULL
nonimmune	NULL
cell	NULL
proliferation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
and	NULL
Media	NULL
.	NULL

-	NULL
Gibbon	NULL
lymphosarcoma-infected	NULL
T	NULL
cells	NULL
,	NULL
MLA-144	NULL
(	NULL
ATCC	NULL
TIB	NULL
201	NULL
)	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rock-ville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco	NULL
Laborato-ries	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
)	NULL
and	NULL
1	NULL
%	NULL
penicillin-streptomycin	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
)	NULL
.	NULL

RNA	NULL
Preparation	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

-	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
MLA-144	NULL
cells	NULL
using	NULL
the	NULL
guanidinium	NULL
isothio-cyanate-cesium	NULL
chloride	NULL
gradient	NULL
method	NULL
(	NULL
31	NULL
)	NULL
.	NULL

RNA	NULL
samples	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
after	NULL
incubation	NULL
with	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
following	NULL
reagents	NULL
:	NULL
PMA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
alone	NULL
and	NULL
with	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
Corp.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
PMA	NULL
alone	NULL
and	NULL
finally	NULL
,	NULL
with	NULL
media	NULL
only	NULL
.	NULL

After	NULL
equalization	NULL
by	NULL
spectrophotometry	NULL
and	NULL
visualization	NULL
in	NULL
agarose	NULL
gels	NULL
containing	NULL
ethidium	NULL
bromide	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose/formaldehyde	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
Hybond-N	NULL
nylon	NULL
filters	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
hybridized	NULL
to	NULL
a	NULL
human	NULL
IL-3	NULL
cDNA	NULL
,	NULL
which	NULL
was	NULL
radiolabeled	NULL
with	NULL
-	NULL
[	NULL
>	NULL
P	NULL
]	NULL
-dCTP	NULL
by	NULL
random	NULL
hexanucleotide	NULL
priming	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Human	NULL
IL3	NULL
Genomic	NULL
Clone	NULL
and	NULL
Plasmid	NULL
Construc	NULL
tion	NULL
.	NULL

A	NULL
genomic	NULL
clone	NULL
containing	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
and	NULL
5	NULL
``	NULL
flanking	NULL
sequences	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
peripheral	NULL
blood	NULL
genomic	NULL
library	NULL
(	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
John	NULL
Lowe	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
by	NULL
hybridization	NULL
to	NULL
a	NULL
human	NULL
IL-3	NULL
cDNA	NULL
probe	NULL
.	NULL

Restriction	NULL
mapping	NULL
of	NULL
the	NULL
IL-3	NULL
clone	NULL
was	NULL
performed	NULL
using	NULL
standard	NULL
techniques	NULL
(	NULL
31	NULL
)	NULL
.	NULL

A	NULL
set	NULL
of	NULL
overlapping	NULL
DNA	NULL
sequences	NULL
from	NULL
the	NULL
5¢	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
were	NULL
cloned	NULL
in	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
orientation	NULL
directly	NULL
5	NULL
``	NULL
of	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
in	NULL
the	NULL
promoterless/enhancerless	NULL
vector	NULL
,	NULL
pCAT-Basic	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Transfections	NULL
.	NULL

-	NULL
Various	NULL
cell	NULL
types	NULL
were	NULL
transfected	NULL
with	NULL
10-20	NULL
ug	NULL
purified	NULL
supercoiled	NULL
plasmid	NULL
DNA	NULL
prepared	NULL
by	NULL
alkaline	NULL
lysis	NULL
and	NULL
cesium-chloride	NULL
banding	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
MLA-144	NULL
,	NULL
Clone	NULL
13	NULL
,	NULL
PEER	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
25	NULL
ug	NULL
of	NULL
Lipofectin	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
)	NULL
.	NULL

2	NULL
ug	NULL
of	NULL
either	NULL
pRSVBGAL	NULL
or	NULL
pRSVluciferase	NULL
DNA	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
to	NULL
correct	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
between	NULL
samples	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

CAT	NULL
,	NULL
3-Galactosidase	NULL
,	NULL
and	NULL
Luciferase	NULL
Assays	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
by	NULL
four	NULL
cycles	NULL
of	NULL
freeze-thaw	NULL
lysis	NULL
,	NULL
and	NULL
protein	NULL
levels	NULL
were	NULL
determined	NULL
using	NULL
a	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
-galactosidase	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
De	NULL
Wet	NULL
(	NULL
34	NULL
)	NULL
using	NULL
lu-ciferin	NULL
substrate	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
and	NULL
a	NULL
Pharmacia	NULL
luminom-eter	NULL
{	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

DNA	NULL
Sequencing	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
double-stranded	NULL
DNA	NULL
templates	NULL
using	NULL
the	NULL
dideoxynucleotide	NULL
chain	NULL
termination	NULL
protocol	NULL
(	NULL
35	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Footprint	NULL
Analysis	NULL
.	NULL

A	NULL
193-bp	NULL
subfragment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-126	NULL
;	NULL
sense	NULL
stand	NULL
)	NULL
of	NULL
the	NULL
flanking	NULL
IL-3	NULL
gene	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
o-	NULL
»	NULL
P	NULL
]	NULL
-dGTP	NULL
and	NULL
[	NULL
-P	NULL
]	NULL
TTP	NULL
with	NULL
the	NULL
large	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
1	NULL
(	NULL
Klenow	NULL
)	NULL
and	NULL
isolated	NULL
by	NULL
PAGE	NULL
.	NULL

The	NULL
labeled	NULL
193-bp	NULL
fragment	NULL
was	NULL
subjected	NULL
to	NULL
partial	NULL
DNase	NULL
I	NULL
digestion	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
,	NULL
after	NULL
incubation	NULL
with	NULL
100-200	NULL
ug	NULL
of	NULL
MLA-144	NULL
nuclear	NULL
protein	NULL
extracts	NULL
.	NULL

Maxam	NULL
and	NULL
Gilbert	NULL
purine	NULL
sequencing	NULL
reactions	NULL
(	NULL
33	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
electrophoresed	NULL
in	NULL
parallel	NULL
to	NULL
the	NULL
DNase	NULL
I	NULL
digested	NULL
subfragments	NULL
.	NULL

EMSAs	NULL
.	NULL

-	NULL
Complementary	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
,	NULL
Elf-1	NULL
,	NULL
NF-IL3	NULL
,	NULL
and	NULL
AP-1/Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
synthesized	NULL
with	NULL
overhanging	NULL
BamHI/Bglll	NULL
ends	NULL
and	NULL
were	NULL
end	NULL
labeled	NULL
using	NULL
Klenow	NULL
as	NULL
described	NULL
above	NULL
before	NULL
EMSA	NULL
:	NULL
AP1/EIf1	NULL
:	NULL
GATCTGAGCTGAGTCAGGCTTCCCCTTCCTGC	NULL
CACAGGG	NULL
MSV	NULL
LTR	NULL
:	NULL
TCGGAGACGGAAGCGCGC	NULL
EIf1	NULL
:	NULL
GATCTTCCCCTTCCTGCCACAGGG	NULL
NF-IL3	NULL
:	NULL
-	NULL
GATCCATGGATGAATAATTA	NULL
AP-i	NULL
:	NULL
GATCTGAGCTGAGTCAGGCTTG	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
except	NULL
that	NULL
the	NULL
binding	NULL
buffer	NULL
included	NULL
4	NULL
%	NULL
Ficoll	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
75	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
500	NULL
ng	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
the	NULL
gels	NULL
were	NULL
run	NULL
in	NULL
0.25	NULL
x	NULL
Tris-boric	NULL
acid-EDTA	NULL
running	NULL
buffer	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
50-200	NULL
ng	NULL
)	NULL
were	NULL
included	NULL
in	NULL
cold	NULL
competition	NULL
experiments	NULL
.	NULL

EMSAs	NULL
included	NULL
either	NULL
3-5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
MLA-144	NULL
cells	NULL
{	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
)	NULL
,	NULL
or	NULL
3	NULL
gl	NULL
of	NULL
in	NULL
vitro-transcribed/	NULL
translated	NULL
protein	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
(	NULL
10	NULL
ng/ml	NULL
PMA	NULL
and	NULL
400	NULL
ng/m	NULL
!	NULL

ionomycin	NULL
for	NULL
6-8	NULL
h	NULL
)	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
purified	NULL
by	NULL
elutriation	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
Drs	NULL
.	NULL

Lawrence	NULL
Boise	NULL
and	NULL
Craig	NULL
Thompson	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
oligonucleotide	NULL
competitors	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
include	NULL
the	NULL
above	NULL
probes	NULL
unlabeled	NULL
and	NULL
:	NULL
mELF-1	NULL
;	NULL
GATCCCTGTGTCTCCTTCGGAA	NULL
MNIP	NULL
:	NULL
GATCCACCTTCTTCACTTGTTCCCA	NULL
Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ul	NULL
of	NULL
rabbit	NULL
or	NULL
mouse	NULL
antisera	NULL
.	NULL

These	NULL
antisera	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
protein	NULL
extracts	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
DNA	NULL
probe	NULL
in	NULL
EMSA	NULL
reactions	NULL
.	NULL

Preparation	NULL
of	NULL
Mutated	NULL
Constructs	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
NF-IL3	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
were	NULL
introduced	NULL
by	NULL
site-directed	NULL
oligo-nucleotide-mediated	NULL
gapped-heteroduplex	NULL
mutagenesis	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
using	NULL
the	NULL
following	NULL
synthetic	NULL
oligonucleotide	NULL
:	NULL
TGAGTACTAGAAAGTCATGGGACTCGAGGTACGTCTGTGG-TTTTCTATGG	NULL
.	NULL

The	NULL
wild-type	NULL
NF-IL3	NULL
site	NULL
(	NULL
ATGAATAA	NULL
)	NULL
was	NULL
changed	NULL
to	NULL
a	NULL
mutagnt	NULL
sequence	NULL
(	NULL
GACTCGAG	NULL
)	NULL
.	NULL

(	NULL
Underlined	NULL
sequences	NULL
denote	NULL
regions	NULL
of	NULL
mutation	NULL
.	NULL
)	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
AP-1	NULL
and	NULL
EIFi	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
using	NULL
the	NULL
PCR	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
with	NULL
the	NULL
following	NULL
oligonucleotides	NULL
:	NULL
1683	NULL
Gottschalk	NULL
et	NULL
al	NULL
.	NULL

AP-1	NULL
:	NULL
GGGCAGGAGGCCTCAGTGAGGTCTCGAGCGCTTCC	NULL
CCTTCCTGCCACAGGG	NULL
Elf1	NULL
:	NULL
CAGTGAGCTGAGTCAGGCTTCCGAAGGAGACACA	NULL
GG	NULL
@	NULL
GGGTCCTCTCACCTGCTGC	NULL
All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

The	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
was	NULL
changed	NULL
from	NULL
the	NULL
wild-type	NULL
sequence	NULL
(	NULL
TGAGTCAG	NULL
)	NULL
to	NULL
a	NULL
mutant	NULL
sequence	NULL
(	NULL
TCTCGAGC	NULL
)	NULL
.	NULL

The	NULL
ELF-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
was	NULL
changed	NULL
from	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
GGCAGGAAGGG	NULL
)	NULL
to	NULL
a	NULL
mutant	NULL
sequence	NULL
(	NULL
TGTCTCCTTCG	NULL
)	NULL
.	NULL

Wild-type	NULL
and	NULL
mutant	NULL
multimerized	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
multimerization	NULL
of	NULL
the	NULL
same	NULL
AP-1/Elf-1	NULL
EMSA	NULL
oligonucleotide	NULL
and	NULL
three	NULL
additional	NULL
ologonucleotides	NULL
:	NULL
AP-1/mEIF-1	NULL
;	NULL
GATCTGAGCTGAGTCAGGCTTCCGCAGCAG-ACACCAGGG	NULL
mAP-1/Elf1	NULL
:	NULL
GATCTGAGGTCTCGAGCGCTTCCCCTTCCT-GCCACAGGG	NULL
mAP-1/mEIlf-1	NULL
:	NULL
GATCTGAGGTCTCGAGCGCTTCCGCAGCAG	NULL
ACACCAGGG	NULL
These	NULL
oligonucleotides	NULL
were	NULL
ligated	NULL
in	NULL
reverse	NULL
orientation	NULL
to	NULL
pSPCAT	NULL
,	NULL
an	NULL
enhancerless	NULL
plasmid	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription/	NULL
Translation	NULL
Reactions	NULL
.	NULL

Linearized	NULL
cDNAs	NULL
corresponding	NULL
to	NULL
full-length	NULL
and	NULL
truncated	NULL
Elf1	NULL
cDNA	NULL
(	NULL
El-11s34	NULL
;	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
Jeffrey	NULL
Leiden	NULL
,	NULL
University	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
were	NULL
transcribed	NULL
using	NULL
10	NULL
U	NULL
T7	NULL
RNA	NULL
polymerase	NULL
,	NULL
40	NULL
U	NULL
RNasin	NULL
ribonuclease	NULL
inhibitor	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
0.4	NULL
mM	NULL
rNTPs	NULL
.	NULL

Transcribed	NULL
RNAs	NULL
were	NULL
then	NULL
translated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.8	NULL
mCi/ml	NULL
[	NULL
*SJmethionine	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
,	NULL
40	NULL
U	NULL
RNasin	NULL
,	NULL
20	NULL
mM	NULL
amino	NULL
acids	NULL
(	NULL
minus	NULL
methionine	NULL
)	NULL
and	NULL
35	NULL
pul	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
translated	NULL
proteins	NULL
was	NULL
assessed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Antibodies	NULL
.	NULL

-	NULL
Rabbit	NULL
polyclonal	NULL
Elf-1	NULL
antiserum	NULL
and	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
Jeffrey	NULL
Leiden	NULL
)	NULL
,	NULL
and	NULL
anti-Jun	NULL
family	NULL
sera	NULL
that	NULL
reacts	NULL
with	NULL
all	NULL
three	NULL
Jun	NULL
proteins	NULL
:	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Jun	NULL
(	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
Rodrigo	NULL
Bravo	NULL
,	NULL
Bristol-Meyers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
NY	NULL
)	NULL
were	NULL
used	NULL
in	NULL
some	NULL
EMSA	NULL
reactions	NULL
.	NULL

The	NULL
Elf1	NULL
antiserum	NULL
does	NULL
not	NULL
react	NULL
with	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
.	NULL

Anti-IL-2	NULL
receptor	NULL
(	NULL
IL-2R	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain-view	NULL
,	NULL
CA	NULL
)	NULL
mouse	NULL
mAb	NULL
was	NULL
used	NULL
in	NULL
control	NULL
reactions	NULL
.	NULL

Results	NULL
Isolation	NULL
and	NULL
Characterization	NULL
of	NULL
a	NULL
Genomic	NULL
Clone	NULL
Containing	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
.	NULL

We	NULL
isolated	NULL
a	NULL
clone	NULL
containing	NULL
the	NULL
full-length	NULL
IL-3	NULL
gene	NULL
from	NULL
a	NULL
human	NULL
genomic	NULL
library	NULL
with	NULL
a	NULL
human	NULL
IL-3	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
standard	NULL
techniques	NULL
.	NULL

This	NULL
clone	NULL
includes	NULL
3	NULL
kb	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
and	NULL
5	NULL
kb	NULL
of	NULL
3	NULL
'	NULL
flanking	NULL
sequence	NULL
.	NULL

To	NULL
identify	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
5	NULL
!	NULL

flanking	NULL
region	NULL
,	NULL
we	NULL
sequenced	NULL
1,400	NULL
bp	NULL
of	NULL
DNA	NULL
5	NULL
``	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
computer	NULL
homology	NULL
search	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
DNA	NULL
sequence	NULL
revealed	NULL
similarities	NULL
to	NULL
potential	NULL
regulatory	NULL
motifs	NULL
not	NULL
previously	NULL
observed	NULL
.	NULL

These	NULL
include	NULL
an	NULL
ets-1	NULL
family	NULL
nuclear	NULL
protooncogene	NULL
binding	NULL
site	NULL
(	NULL
EBS	NULL
)	NULL
with	NULL
one	NULL
mismatch	NULL
(	NULL
bp	NULL
-288	NULL
to	NULL
-278	NULL
;	NULL
antisense	NULL
strand	NULL
;	NULL
GGCAGGAAGGG	NULL
)	NULL
(	NULL
37-40	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
this	NULL
EBS	NULL
contains	NULL
an	NULL
A.	NULL
AGGCCCAGTTGAAACCAGGGAGTTGCTCTCCTTTCTCCTCCCTTGACCTCACCCCTCAGACCATGCCAATTC	NULL
TGCCTCCTAARCCTCCCAGGCCAGCCCCTCCCCCAGCTCCCAGTGACAGTGTCCTCAGGTACCTGAGCTCAG	NULL
NIP	NULL
CTCTCGGTGCTACCAGAGGGACTGCAGGGCTGCAGAGGCTEACTCCCACACGCAGGGAAGAGCCATGCCACT	NULL
GCTAGCAGACCAGTAAGAGAATGGCCACCTGGGGCCTGAGCGCCCTCGGCCATCCACCAGARACAAAGTGTC	NULL
ARGGAGARGCTGCCCGAAGCCCATGGGACAAACCACTGGGGACTGGAACACCAGTAATTCTGTATTGGGAAG	NULL
CGGCACCAAGAGATCTGCTTCTCAGAGCCTGAGGCTGAACGTGGATGTTTAGCAGCGTGACCGGCTACCAGA	NULL
CAAACTCTCATCTGTTCCAGTGGCCTCCTGGCCACCCACCAGGACCAAGCAGGECGEGCAGCAGAGGGCCAG	NULL
-317	NULL
AP~1	NULL
GGTAGTCCAGGTGATGGCAGATGAGATCCCACTGGGCAGCAGGCCTCAGTCAGC	NULL
Elf-1	NULL
~270	NULL
NIP	NULL
EBS	NULL
CCTSCCACAGGGGTCCTCTCACCTECRERCATGCTTCCCATCTCTCATCCTCCTTGACAAGATGAAGTGATA	NULL
NEIL-3	NULL
``	NULL
CRE	NULL
``	NULL
-175	NULL
{	NULL
ACT-1B	NULL
)	NULL
(	NULL
ACT-1A	NULL
)	NULL
CCGTTTAAGTAATCTTTTTTCTTGTTICACTIGATCTTGAGTACTAGAAAGTCATG	NULL
CKk-1/CD28R	NULL
CKk-2/GATA3	NULL
|	NULL
Eas	NULL
cace	NULL
Sp1	NULL
GaCGCCreccecacaccaccacertecccce	NULL
1	NULL
CCTIGCCCGGGGTTETGGGCACCTTECTGCTGCACATATAAGGCGGGAGCTGTTGCCAACTCTTCAGAGCCC	NULL
Start	NULL
of	NULL
|	NULL
Transcription	NULL
CACGAAGGACCAGAACAAGACAGAGTGCCTCCTGCCGATCCAAACATGAGCCGCC	NULL
I	NULL
Coding	NULL
sequences	NULL
B.	NULL
AA	NULL
AGGAGGATGTG	NULL
6	NULL
GACC	NULL
CAA	NULL
TRE	NULL
:	NULL
TGAGTCAG	NULL
-277	NULL
:	NULL
5°	NULL
Gecaccamcge	NULL
3	NULL
``	NULL
~301	NULL
:	NULL
5°	NULL
TGAGTCAG	NULL
3°	NULL
A	NULL
AP~1	NULL
:	NULL
TGACTCA	NULL
EBS	NULL
:	NULL
Figure	NULL
1	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
from	NULL
-855	NULL
to	NULL
the	NULL
start	NULL
of	NULL
coding	NULL
sequences	NULL
is	NULL
depicted	NULL
.	NULL

Sequences	NULL
similar	NULL
to	NULL
known	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
and	NULL
those	NULL
defined	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
are	NULL
underlined	NULL
and	NULL
identified	NULL
.	NULL

The	NULL
consensus	NULL
sequences	NULL
for	NULL
the	NULL
AP-1	NULL
and	NULL
ets	NULL
family	NULL
binding	NULL
sites	NULL
(	NULL
EBS	NULL
)	NULL
,	NULL
and	NULL
comparison	NULL
to	NULL
sequences	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
are	NULL
shown	NULL
in	NULL
B	NULL
.	NULL

The	NULL
single	NULL
divergent	NULL
base	NULL
is	NULL
underlined	NULL
.	NULL

These	NULL
sequence	NULL
data	NULL
are	NULL
available	NULL
from	NULL
EMBL	NULL
/GenBank/DDBJ	NULL
under	NULL
accession	NULL
number	NULL
L10616	NULL
.	NULL

A	NULL
at	NULL
nucleotide	NULL
8	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
permit	NULL
binding	NULL
to	NULL
the	NULL
Elf-1	NULL
transcription	NULL
factor	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Two	NULL
additional	NULL
EBS	NULL
are	NULL
present	NULL
in	NULL
the	NULL
IL-3	NULL
5	NULL
flanking	NULL
sequences	NULL
(	NULL
-108	NULL
to	NULL
~98	NULL
;	NULL
-230	NULL
to	NULL
-220	NULL
)	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
CD28-responsive	NULL
element	NULL
(	NULL
CD28R	NULL
;	NULL
bp	NULL
-126	NULL
to	NULL
~116	NULL
;	NULL
GAGGTTCCATG	NULL
)	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
a	NULL
CD28-responsive	NULL
element	NULL
is	NULL
of	NULL
interest	NULL
because	NULL
earlier	NULL
studies	NULL
in	NULL
this	NULL
laboratory	NULL
demonstrated	NULL
that	NULL
IL-3	NULL
gene	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
the	NULL
CD28	NULL
*	NULL
T	NULL
cell	NULL
subpopulation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Contained	NULL
within	NULL
the	NULL
lymphokine	NULL
CK-2	NULL
motif	NULL
is	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
GATA-3	NULL
transcription	NULL
factor	NULL
(	NULL
AGATAA	NULL
)	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
this	NULL
site	NULL
is	NULL
conserved	NULL
within	NULL
murine	NULL
IL-3	NULL
gene	NULL
sequences	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
site	NULL
similar	NULL
in	NULL
8	NULL
of	NULL
10	NULL
bp	NULL
to	NULL
the	NULL
NIP	NULL
inhibitory	NULL
motif	NULL
(	NULL
19	NULL
)	NULL
is	NULL
located	NULL
657	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

Identification	NULL
of	NULL
cis-	NULL
Acting	NULL
Transcriptional	NULL
Regulatory	NULL
Sequences	NULL
that	NULL
May	NULL
Be	NULL
Involved	NULL
in	NULL
T	NULL
Cell-Restricted	NULL
IL-3	NULL
Gene	NULL
Expres	NULL
sion	NULL
.	NULL

-	NULL
In	NULL
an	NULL
effort	NULL
to	NULL
define	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
that	NULL
modulate	NULL
IL-3	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
a	NULL
series	NULL
of	NULL
heterologous	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
and	NULL
human	NULL
genomic	NULL
IL-3	NULL
subfragments	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

Initially	NULL
,	NULL
a	NULL
set	NULL
of	NULL
contiguous	NULL
DNA	NULL
segments	NULL
from	NULL
the	NULL
5	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
was	NULL
cloned	NULL
in	NULL
5°	NULL
to	NULL
3	NULL
'	NULL
orientation	NULL
directly	NULL
5	NULL
``	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
promoterless/enhancerless	NULL
vector	NULL
,	NULL
pCAT-basic	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
constructs	NULL
containing	NULL
150	NULL
bp	NULL
(	NULL
which	NULL
includes	NULL
the	NULL
CK-1	NULL
,	NULL
CK-2	NULL
,	NULL
and	NULL
CRE	NULL
elements	NULL
)	NULL
and	NULL
175	NULL
bp	NULL
(	NULL
which	NULL
includes	NULL
the	NULL
CK-1	NULL
,	NULL
1684	NULL
+319	NULL
+270	NULL
~175	NULL
-150	NULL
Cell	NULL
Line	NULL
_	NULL
Activation	NULL
_	NULL
-150CAT	NULL
__	NULL
-175CAT	NULL
__-270CAT	NULL
__	NULL
-319CAT	NULL
Jurkat	NULL
=	NULL
82	NULL
0.5	NULL
420.6	NULL
120.4	NULL
421	NULL
+	NULL
128	NULL
:	NULL
2	NULL
882	NULL
14	NULL
220.7	NULL
372	NULL
10	NULL
PEER	NULL
*	NULL
1	NULL
1	NULL
1	NULL
1	NULL
+	NULL
211	NULL
2	NULL
651	NULL
27	NULL
1	NULL
1192	NULL
39	NULL
MLA-144	NULL
=	NULL
51	NULL
0.8	NULL
122	NULL
8	NULL
120.5	NULL
1024	NULL
+	NULL
B62	NULL
32	NULL
1152	NULL
41	NULL
341	NULL
158	NULL
:	NULL
62	NULL
Clone	NULL
13	NULL
-	NULL
*	NULL
810.3	NULL
3	NULL
1	NULL
220.7	NULL
+	NULL
1823	NULL
162	NULL
4	NULL
1	NULL
220.3	NULL
Hela	NULL
-	NULL
2511	NULL
1324	NULL
1	NULL
1	NULL
Figure	NULL
2	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
CAT	NULL
constructs	NULL
containing	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
DNA	NULL
segments	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

IL-3-CAT	NULL
constructs	NULL
containing	NULL
150-319	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
with	NULL
30	NULL
bp	NULL
of	NULL
55	NULL
untranslated	NULL
DNA	NULL
cloned	NULL
into	NULL
pCAT	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
and	NULL
MLA-144	NULL
T	NULL
cells	NULL
,	NULL
into	NULL
Clone	NULL
13	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
into	NULL
Hela	NULL
fibroblasts	NULL
,	NULL
along	NULL
with	NULL
an	NULL
efficiency	NULL
plasmid	NULL
,	NULL
pRSV	NULL
gal	NULL
or	NULL
pRSVluciferase	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
transcriptional	NULL
activity	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
that	NULL
these	NULL
constructs	NULL
included	NULL
are	NULL
shown	NULL
at	NULL
top	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
groups	NULL
:	NULL
the	NULL
first	NULL
was	NULL
maintained	NULL
in	NULL
media	NULL
only	NULL
while	NULL
the	NULL
second	NULL
was	NULL
induced	NULL
with	NULL
activation	NULL
agents	NULL
known	NULL
to	NULL
elicit	NULL
IL-3	NULL
.	NULL

The	NULL
activation	NULL
agents	NULL
(	NULL
denoted	NULL
by	NULL
+	NULL
)	NULL
used	NULL
in	NULL
Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
and	NULL
Clone	NULL
13	NULL
cells	NULL
were	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
400	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
those	NULL
used	NULL
in	NULL
MLA-144	NULL
cells	NULL
were	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
various	NULL
cell	NULL
lines	NULL
were	NULL
induced	NULL
for	NULL
6-8	NULL
h	NULL
before	NULL
the	NULL
harvest	NULL
of	NULL
extracts	NULL
,	NULL
and	NULL
these	NULL
extracts	NULL
,	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiencies	NULL
,	NULL
were	NULL
used	NULL
in	NULL
CAT	NULL
assays	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
table	NULL
{	NULL
mean	NULL
and	NULL
SD	NULL
)	NULL
and	NULL
represents	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
a	NULL
particular	NULL
construct	NULL
compared	NULL
to	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
the	NULL
pCAT	NULL
vector	NULL
alone	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
tested	NULL
four	NULL
times	NULL
in	NULL
Jurkat	NULL
,	NULL
PEER	NULL
,	NULL
and	NULL
MLA-144	NULL
cells	NULL
,	NULL
three	NULL
times	NULL
in	NULL
Clone	NULL
13	NULL
cells	NULL
and	NULL
twice	NULL
in	NULL
Hela	NULL
cells	NULL
with	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

CK-2	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
NF-IL-3	NULL
elements	NULL
)	NULL
of	NULL
5	NULL
``	NULL
flanking	NULL
sequence	NULL
(	NULL
with	NULL
30	NULL
bp	NULL
of	NULL
5	NULL
untranslated	NULL
sequences	NULL
)	NULL
increased	NULL
CAT	NULL
activity	NULL
after	NULL
activation	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
transfected	NULL
Hela	NULL
cells	NULL
and	NULL
lower	NULL
level	NULL
activity	NULL
was	NULL
demonstrated	NULL
in	NULL
unstimulated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
319	NULL
bp	NULL
of	NULL
5°	NULL
flanking	NULL
sequence	NULL
was	NULL
active	NULL
exclusively	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Deletion	NULL
analysis	NULL
demonstrated	NULL
that	NULL
this	NULL
activity	NULL
was	NULL
lost	NULL
in	NULL
T	NULL
cells	NULL
when	NULL
49	NULL
bp	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
319-bp	NULL
construct	NULL
,	NULL
and	NULL
this	NULL
construct	NULL
was	NULL
also	NULL
inactive	NULL
in	NULL
non-T	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
49-bp	NULL
DNA	NULL
segment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-270	NULL
)	NULL
contains	NULL
a	NULL
consensus	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
bp	NULL
-301	NULL
to	NULL
-295	NULL
)	NULL
6	NULL
bp	NULL
5	NULL
'	NULL
to	NULL
the	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
described	NULL
above	NULL
.	NULL

Such	NULL
an	NULL
AP-1/Ets	NULL
family	NULL
member	NULL
nuclear	NULL
protein	NULL
binding	NULL
cassette	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
other	NULL
cytokine	NULL
genes	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Although	NULL
-270CAT	NULL
included	NULL
the	NULL
putative	NULL
silencer	NULL
NIP	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NIP	NULL
site	NULL
from	NULL
GCTGCCATGC	NULL
to	NULL
TCTTCA-CTTG	NULL
in	NULL
the	NULL
context	NULL
of	NULL
-270CAT	NULL
failed	NULL
to	NULL
increase	NULL
CAT	NULL
activity	NULL
in	NULL
MLA-144	NULL
T	NULL
cells	NULL
or	NULL
in	NULL
Clone	NULL
13	NULL
B	NULL
cells	NULL
to	NULL
the	NULL
level	NULL
demonstrated	NULL
by	NULL
~175CAT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
additional	NULL
DNA	NULL
sequence	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
regardless	NULL
of	NULL
the	NULL
status	NULL
of	NULL
NIP	NULL
site	NULL
integrity	NULL
,	NULL
or	NULL
that	NULL
the	NULL
low-level	NULL
activity	NULL
given	NULL
by	NULL
-270CAT	NULL
is	NULL
not	NULL
en-	NULL
Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
tirely	NULL
due	NULL
to	NULL
the	NULL
NIP	NULL
site	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
49-bp	NULL
fragment	NULL
is	NULL
required	NULL
for	NULL
the	NULL
T	NULL
cell-restricted	NULL
pattern	NULL
of	NULL
IL-3	NULL
gene	NULL
expression	NULL
and	NULL
that	NULL
it	NULL
may	NULL
function	NULL
in	NULL
concert	NULL
with	NULL
other	NULL
negative	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
IL-3	NULL
promoter	NULL
.	NULL

Activation	NULL
of	NULL
ML	NULL
A-144	NULL
Cells	NULL
Induces	NULL
High-level	NULL
IL-3	NULL
Gene	NULL
Transcripts	NULL
and	NULL
Nuclear	NULL
Proteins	NULL
that	NULL
Bind	NULL
to	NULL
DNA	NULL
Sequences	NULL
within	NULL
the	NULL
49-bp	NULL
Fragment	NULL
in	NULL
the	NULL
5°	NULL
Flanking	NULL
Sequences	NULL
of	NULL
the	NULL
IL-3	NULL
Gene	NULL
.	NULL

To	NULL
study	NULL
further	NULL
the	NULL
role	NULL
of	NULL
the	NULL
49-bp	NULL
fragment	NULL
in	NULL
IL-3	NULL
gene	NULL
transcription	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
identify	NULL
cells	NULL
that	NULL
could	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-3	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
obtained	NULL
from	NULL
Jurkat	NULL
and	NULL
PEER	NULL
T	NULL
cells	NULL
revealed	NULL
that	NULL
these	NULL
cells	NULL
produced	NULL
extremely	NULL
low	NULL
levels	NULL
of	NULL
IL-3	NULL
gene	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
,	NULL
MLA-144	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
incubation	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
to	NULL
produce	NULL
high	NULL
levels	NULL
of	NULL
IL-3	NULL
gene	NULL
transcripts	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
after	NULL
incubation	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
400	NULL
ng/ml	NULL
)	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
alone	NULL
.	NULL

These	NULL
levels	NULL
were	NULL
comparable	NULL
with	NULL
levels	NULL
of	NULL
IL-3	NULL
expression	NULL
obtained	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
L.	NULL
Gottschalk	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
no	NULL
IL-3	NULL
gene	NULL
transcription	NULL
was	NULL
detected	NULL
in	NULL
RNA	NULL
prepared	NULL
from	NULL
cells	NULL
incubated	NULL
with	NULL
media	NULL
alone	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
that	NULL
,	NULL
unlike	NULL
other	NULL
inducible	NULL
cytokine	NULL
genes	NULL
,	NULL
IL-3	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
induced	NULL
with	NULL
PHA	NULL
alone	NULL
(	NULL
8	NULL
)	NULL
and	NULL
suggest	NULL
that	NULL
relatively	NULL
unique	NULL
molecular	NULL
mechanisms	NULL
may	NULL
regulate	NULL
IL-3	NULL
gene	NULL
transcription	NULL
.	NULL

To	NULL
identify	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
49-bp	NULL
subfragment	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
promoter	NULL
that	NULL
conferred	NULL
T	NULL
cell	NULL
specificity	NULL
in	NULL
CAT	NULL
assay	NULL
studies	NULL
,	NULL
we	NULL
subjected	NULL
a	NULL
193-bp	NULL
DNA	NULL
subfragment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-126	NULL
;	NULL
sense	NULL
strand	NULL
)	NULL
containing	NULL
the	NULL
49-bp	NULL
segment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-270	NULL
)	NULL
to	NULL
DNasel	NULL
footprint	NULL
analysis	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
A	NULL
.	NULL

€	NULL
©	NULL
E	NULL
2	NULL
o	NULL
.	NULL

6	NULL
goo	NULL
+	NULL
+	NULL
<	NULL
E	NULL
G	NULL
4	NULL
4	NULL
4	NULL
4	NULL
+5	NULL
$	NULL
3	NULL
5	NULL
s	NULL
T	NULL
o	NULL
=	NULL
c	NULL
q	NULL
a	NULL
a	NULL
rna	NULL
$	NULL
}	NULL
IL-3	NULL
#	NULL
||	NULL
4	NULL
|	NULL
B-actin	NULL
.	NULL

.	NULL

..	NULL
%	NULL
s	NULL
e	NULL
C.	NULL
314	NULL
APA	NULL
Elfi	NULL
=	NULL
eaccTtcactGacpTeaActcaceertrcccerrecrecca	NULL
]	NULL
caceearcere	NULL
=	NULL
12345	NULL
1685	NULL
Gottschalk	NULL
et	NULL
al	NULL
.	NULL

100	NULL
ug	NULL
uns	NULL
150	NULL
ug	NULL
uns	NULL
200	NULL
ug	NULL
uns	NULL
and	NULL
C	NULL
shows	NULL
that	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
MLA-144	NULL
cells	NULL
protected	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
Elf-1	NULL
site	NULL
,	NULL
and	NULL
intervening	NULL
DNA	NULL
from	NULL
digestion	NULL
by	NULL
DNasel	NULL
(	NULL
bracketed	NULL
and	NULL
boxed	NULL
)	NULL
and	NULL
that	NULL
no	NULL
other	NULL
regions	NULL
in	NULL
the	NULL
49-bp	NULL
segment	NULL
within	NULL
the	NULL
193-bp	NULL
fragment	NULL
bound	NULL
nuclear	NULL
proteins	NULL
.	NULL

Because	NULL
these	NULL
sites	NULL
were	NULL
protected	NULL
by	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
ML	NULL
A-144	NULL
cells	NULL
,	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
IL-3	NULL
gene	NULL
DNA	NULL
was	NULL
performed	NULL
by	NULL
EMSAs	NULL
.	NULL

ML	NULL
A-144	NULL
Cells	NULL
Contain	NULL
Multiple	NULL
Specific	NULL
Nuclear	NULL
Proteins	NULL
that	NULL
Bind	NULL
to	NULL
DNA	NULL
Sequences	NULL
in	NULL
the	NULL
IL-3	NULL
Promoter	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
number	NULL
and	NULL
the	NULL
specificity	NULL
of	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
protected	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
49-bp	NULL
IL-3	NULL
gene	NULL
subfragment	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
EMSAs	NULL
with	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
and	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
A	NULL
shows	NULL
that	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
ML	NULL
A-144	NULL
cells	NULL
were	NULL
tested	NULL
with	NULL
the	NULL
AP-1/Elf1	NULL
DNA	NULL
probe	NULL
(	NULL
including	NULL
intervening	NULL
DNA	NULL
)	NULL
,	NULL
four	NULL
low-mobility	NULL
bands	NULL
{	NULL
arrows	NULL
)	NULL
bound	NULL
specifically	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
competition	NULL
with	NULL
wild-type	NULL
oligonucleotides	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
DNA	NULL
competitor	NULL
(	NULL
MNIP	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
Elf-1	NULL
DNA	NULL
competitor	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Specific	NULL
bands	NULL
were	NULL
also	NULL
demonstrated	NULL
using	NULL
stimulated	NULL
ML	NULL
A-144	NULL
extracts	NULL
;	NULL
however	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
lowest	NULL
mobility	NULL
band	NULL
,	NULL
the	NULL
bands	NULL
were	NULL
difficult	NULL
to	NULL
distinguish	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
highest	NULL
mobility	NULL
bands	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
specific	NULL
because	NULL
they	NULL
are	NULL
present	NULL
despite	NULL
the	NULL
addition	NULL
of	NULL
wild-type	NULL
DNA	NULL
competitors	NULL
.	NULL

Further	NULL
cold	NULL
competition	NULL
experiments	NULL
revealed	NULL
that	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
consensus	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
competed	NULL
the	NULL
middle	NULL
complexes	NULL
in	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
11	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Figure	NULL
3	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
MLA-144	NULL
RNA	NULL
and	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
human	NULL
IL-3	NULL
expression	NULL
in	NULL
MLA-144	NULL
cells	NULL
during	NULL
activation	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
MLA-144	NULL
cells	NULL
incubated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
either	NULL
media	NULL
alone	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
400	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
alone	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/m	NULL
!	NULL
)	NULL

alone	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
RNA	NULL
from	NULL
each	NULL
condition	NULL
was	NULL
equalized	NULL
for	NULL
28S	NULL
$	NULL
and	NULL
18	NULL
$	NULL
ribosomal	NULL
RNA	NULL
,	NULL
fractionated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nylon	NULL
.	NULL

The	NULL
nylon	NULL
filter	NULL
was	NULL
hybridized	NULL
to	NULL
a	NULL
radiolabeled	NULL
human	NULL
IL	NULL
3	NULL
DNA	NULL
probe	NULL
and	NULL
later	NULL
hybridized	NULL
to	NULL
a	NULL
human	NULL
-actin	NULL
DNA	NULL
probe	NULL
and	NULL
the	NULL
resulting	NULL
+	NULL
autoradiograms	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
anal-	NULL
#	NULL
1	NULL
ysis	NULL
of	NULL
the	NULL
5¢	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
.	NULL

A	NULL
193-bp	NULL
fragment	NULL
(	NULL
bp	NULL
-319	NULL
to	NULL
-126	NULL
;	NULL
sense	NULL
strand	NULL
)	NULL
was	NULL
**	NULL
end	NULL
labeled	NULL
and	NULL
incubated	NULL
with	NULL
unstimulated	NULL
(	NULL
uns	NULL
)	NULL
or	NULL
with	NULL
A	NULL
stimulated	NULL
(	NULL
stim	NULL
)	NULL
or	NULL
without	NULL
(	NULL
Control	NULL
)	NULL
MLA-144	NULL
nuclear	NULL
extract	NULL
before	NULL
partial	NULL
digestion	NULL
with	NULL
DNase	NULL
I	NULL
.	NULL

Standard	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
purine	NULL
(	NULL
G	NULL
+	NULL
A	NULL
)	NULL
sequencing	NULL
reactions	NULL
of	NULL
the	NULL
same	NULL
fragment	NULL
were	NULL
prepared	NULL
and	NULL
run	NULL
in	NULL
parallel	NULL
.	NULL

=	NULL
>	NULL
The	NULL
protected	NULL
DNA	NULL
segment	NULL
that	NULL
includes	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
-	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
is	NULL
marked	NULL
with	NULL
brackets	NULL
in	NULL
%	NULL
B	NULL
and	NULL
boxed	NULL
within	NULL
the	NULL
DNA	NULL
sequence	NULL
in	NULL
C.	NULL
The	NULL
AP-1	NULL
678	NULL
and	NULL
Elf1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
in	NULL
C.	NULL
G	NULL
+A	NULL
§	NULL
Control	NULL
@	NULL
150	NULL
ug	NULL
stim	NULL
a	NULL
|	NULL
A	NULL
.	NULL

B.	NULL
fot	NULL
=	NULL
a	NULL
a	NULL
-	NULL
rd	NULL
-	NULL
#	NULL
-	NULL
&	NULL
poe	NULL
&	NULL
0	NULL
$	NULL
..	NULL
es	NULL
fullbali	NULL
do	NULL
&	NULL
§	NULL
4	NULL
&	NULL
dol	NULL
§	NULL
doz	NULL
Competiton	NULL
|	NULL
2	NULL
<	NULL
&	NULL
Competiton	NULL
|	NULL
<	NULL
w	NULL
E	NULL
<	NULL
2	NULL
1	NULL
<	NULL
w	NULL
E	NULL
<	NULL
z	NULL
Nuclear	NULL
Extracts	NULL
:	NULL
--	NULL
Unstimulated	NULL
___	NULL
Stimulated	NULL
wn	NULL
wt	NULL
-_	NULL
--	NULL
»	NULL
¥	NULL
-a	NULL
ObaP-	NULL
-	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
T	NULL
8	NULL
9	NULL
10	NULL
i1	NULL
12	NULL
102	NULL
3	NULL
&	NULL
f	NULL
__	NULL
``	NULL
2	NULL
2	NULL
2	NULL
f	NULL
1	NULL
L	NULL
___	NULL
Probe	NULL
:	NULL
AP-VEI	NULL
Probe	NULL
APA	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
EMSA	NULL
analyses	NULL
of	NULL
the	NULL
AP-1/EIF1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
.	NULL

(	NULL
4	NULL
)	NULL
EMSA	NULL
using	NULL
a	NULL
radiolabeled	NULL
AP-1/Elf-1	NULL
DNA	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
PMA/PHA-stimulated	NULL
ML	NULL
A-144	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200	NULL
ng	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
competitors	NULL
as	NULL
marked	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
analyses	NULL
using	NULL
radiolabeled	NULL
AP-1	NULL
as	NULL
a	NULL
probe	NULL
with	NULL
stimulated	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
.	NULL

Unia-beled	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
200	NULL
ng	NULL
)	NULL
were	NULL
used	NULL
as	NULL
marked	NULL
.	NULL

competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
Elf-1	NULL
site	NULL
alone	NULL
showed	NULL
that	NULL
the	NULL
lowest	NULL
mobility	NULL
specific	NULL
band	NULL
is	NULL
competed	NULL
when	NULL
mixed	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
probe	NULL
and	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
extracts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
when	NULL
an	NULL
Elf-1	NULL
DNA	NULL
competitor	NULL
is	NULL
added	NULL
in	NULL
EMSA	NULL
at	NULL
the	NULL
same	NULL
time	NULL
with	NULL
AP-1	NULL
DNA	NULL
competitor	NULL
,	NULL
the	NULL
lower	NULL
predominant	NULL
band	NULL
evident	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
11	NULL
(	NULL
AP-1	NULL
DNA	NULL
competitor	NULL
alone	NULL
)	NULL
is	NULL
reduced	NULL
suggesting	NULL
that	NULL
there	NULL
are	NULL
two	NULL
bands	NULL
that	NULL
run	NULL
with	NULL
similar	NULL
mobility	NULL
,	NULL
one	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
and	NULL
one	NULL
binding	NULL
to	NULL
the	NULL
EIf-1	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
the	NULL
EMSAs	NULL
demonstrate	NULL
specific	NULL
and	NULL
distinct	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
proteins	NULL
from	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
MLA-144	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
B	NULL
shows	NULL
that	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
specifically	NULL
bound	NULL
nuclear	NULL
proteins	NULL
from	NULL
stimulated	NULL
ML	NULL
A-144	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
EIf-1	NULL
site	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
probe	NULL
described	NULL
above	NULL
to	NULL
those	NULL
formed	NULL
with	NULL
the	NULL
AP-1	NULL
probe	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
and	NULL
the	NULL
Elf-1	NULL
probe	NULL
alone	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
demonstrate	NULL
that	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
probe	NULL
may	NULL
require	NULL
cooperative	NULL
binding	NULL
of	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
or	NULL
of	NULL
yet	NULL
undefined	NULL
transcription	NULL
factors	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
unlabeled	NULL
NF-IL-3	NULL
competitor	NULL
eliminated	NULL
all	NULL
complex	NULL
formation	NULL
observed	NULL
with	NULL
a	NULL
labeled	NULL
AP-1	NULL
consensus	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
stimulated	NULL
extracts	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
NF-IL-3	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
may	NULL
bind	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
AP-1/Elf1	NULL
DNA	NULL
Probe	NULL
Binds	NULL
In	NULL
Vitro	NULL
Transcribed/Trans-lated	NULL
Elf-1	NULL
Protein	NULL
and	NULL
Is	NULL
Competed	NULL
by	NULL
Anti-Elf-1	NULL
Sera	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
Elf-1	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
EBS	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
truncated	NULL
and	NULL
full-length	NULL
in	NULL
vitro-transcribed/translated	NULL
Elf-1	NULL
protein	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
DNA	NULL
probe	NULL
.	NULL

Because	NULL
truncated	NULL
EIlf-1	NULL
protein	NULL
(	NULL
Elf-li0es	NULL
»	NULL
)	NULL
binds	NULL
with	NULL
equivalent	NULL
specificity	NULL
as	NULL
full-length	NULL
Elf-1	NULL
protein	NULL
(	NULL
44	NULL
)	NULL
and	NULL
because	NULL
of	NULL
higher	NULL
translation	NULL
efficiency	NULL
of	NULL
smaller	NULL
transcripts	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
truncated	NULL
version	NULL
was	NULL
used	NULL
in	NULL
competition	NULL
experiments	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
AP-1/Elf-1	NULL
DNA	NULL
probe	NULL
bound	NULL
truncated	NULL
Elf-1	NULL
(	NULL
Elf	NULL
1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
activity	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
Elf-1	NULL
competitor	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
but	NULL
was	NULL
still	NULL
present	NULL
when	NULL
nonspecific	NULL
DNA	NULL
competitor	NULL
was	NULL
added	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
no	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
when	NULL
in	NULL
vitro	NULL
translation	NULL
reactions	NULL
without	NULL
transcribed	NULL
RNA	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
control	NULL
probe	NULL
that	NULL
contains	NULL
an	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
MSV	NULL
LTR	NULL
(	NULL
MSV	NULL
)	NULL
bound	NULL
the	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
translated	NULL
tElf-1	NULL
protein	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

These	NULL
EMSA	NULL
data	NULL
demonstrate	NULL
that	NULL
Elf-1	NULL
protein	NULL
can	NULL
bind	NULL
directly	NULL
to	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
,	NULL
Addition	NULL
of	NULL
Elf1	NULL
and	NULL
Jun	NULL
Antisera	NULL
Block	NULL
Complex	NULL
Formation	NULL
in	NULL
EMSA	NULL
Reactions	NULL
with	NULL
ML	NULL
A-144	NULL
Nuclear	NULL
Extracts	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
proteins	NULL
within	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
that	NULL
bind	NULL
to	NULL
IL-3	NULL
promoter	NULL
DNA	NULL
sequences	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
as	NULL
above	NULL
with	NULL
anti-Jun	NULL
and	NULL
anti-Elf-1	NULL
antisera	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
shows	NULL
that	NULL
addition	NULL
of	NULL
anti-Jun	NULL
family	NULL
serum	NULL
which	NULL
recognizes	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Jun	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
middle	NULL
complexes	NULL
with	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
ML	NULL
A-144	NULL
nuclear	NULL
extracts	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
with	NULL
3	NULL
and	NULL
10	NULL
)	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
the	NULL
same	NULL
bands	NULL
were	NULL
blocked	NULL
by	NULL
addition	NULL
of	NULL
consensus	NULL
AP-1	NULL
DNA	NULL
competitor	NULL
.	NULL

When	NULL
specific	NULL
anti-Elf-1	NULL
serum	NULL
was	NULL
added	NULL
into	NULL
the	NULL
EMSA	NULL
reactions	NULL
,	NULL
it	NULL
was	NULL
difficult	NULL
to	NULL
demonstrate	NULL
the	NULL
disappearance	NULL
of	NULL
a	NULL
band	NULL
using	NULL
the	NULL
AP-1/	NULL
Elf-1	NULL
DNA	NULL
probe	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
higher	NULL
mobility	NULL
band	NULL
(	NULL
closed	NULL
arrow	NULL
)	NULL
formation	NULL
was	NULL
blocked	NULL
in	NULL
EMSA	NULL
reactions	NULL
containing	NULL
the	NULL
shorter	NULL
Elf-1	NULL
DNA	NULL
probe	NULL
(	NULL
-ELF-1	NULL
;	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
lower	NULL
band	NULL
ran	NULL
with	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
1	NULL
I	NULL
To	NULL
``	NULL
*I	NULL
&	NULL
ere	NULL
0	NULL
pon	NULL
0	NULL
Ya	NULL
ipa	NULL
We	NULL
«	NULL
In	NULL
V|t_ro	NULL
i	NULL
i	NULL
{	NULL
|A	NULL
©	NULL
Translated	NULL
Protein	NULL
:	NULL
.	NULL

L	NULL
w	NULL
w	NULL
wo	NULL
.	NULL

WL	NULL
AP-A1/EIf-1	NULL
~~	NULL
]	NULL
MNIP	NULL
Competitor	NULL
(	NULL
ng	NULL
)	NULL
:	NULL
o	NULL
o	NULL
100	NULL
200	NULL
200	NULL
0	NULL
0	NULL
esen	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
L_	NULL
AP-1/Elf-1	NULL
_	NULL
MSV	NULL
Figure	NULL
5	NULL
.	NULL

EMSA	NULL
with	NULL
either	NULL
a	NULL
radiolabeled	NULL
AP-1/Elf-1	NULL
probe	NULL
or	NULL
MSV	NULL
probe	NULL
and	NULL
in	NULL
vitro-transcribed/translated	NULL
truncated	NULL
Elf-1	NULL
(	NULL
t-Elf-1	NULL
)	NULL
or	NULL
translation	NULL
products	NULL
prepared	NULL
without	NULL
RNA	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Lanes	NULL
in	NULL
which	NULL
unlabeled	NULL
oligonucleotide	NULL
competitor	NULL
was	NULL
added	NULL
and	NULL
the	NULL
amounts	NULL
used	NULL
are	NULL
noted	NULL
.	NULL

1686	NULL
Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
~	NULL
€	NULL
8	NULL
&	NULL
>	NULL
@	NULL
>	NULL
.	NULL

C	NULL
c	NULL
s	NULL
c	NULL
i=	NULL
3	NULL
3	NULL
E	NULL
3	NULL
E	NULL
3	NULL
E	NULL
S	NULL
E	NULL
S	NULL
€§	NULL
cos	NULL
§	NULL
$	NULL
§	NULL
r	NULL
$	NULL
§	NULL
s	NULL
T	NULL
2a	NULL
w	NULL
<	NULL
£0	NULL
u	NULL
§	NULL
<	NULL
4	NULL
©	NULL
Anti-Sera	NULL
:	NULL
&	NULL
&	NULL
8	NULL
3	NULL
3	NULL
£8	NULL
3	NULL
T	NULL
Pott	NULL
-a	NULL
Extracts	NULL
:	NULL
Unstimulated	NULL
Stimulated	NULL
aa	NULL
&	NULL
a	NULL
to	NULL
Po	NULL
<	NULL
-	NULL
<	NULL
-	NULL
.	NULL

l	NULL
<	NULL
-	NULL
f-Elf1	NULL
.	NULL

i	NULL
«	NULL
--	NULL
-	NULL
8	NULL
9	NULL
10	NULL
11	NULL
10	NULL
2	NULL
3	NULL
40	NULL
50	NULL
6	NULL
7	NULL
L_	NULL
L_j	NULL
Probe	NULL
:	NULL
AP-1/E1f-1	NULL
Elf-1	NULL
AP-1/Elf-1	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
AP-1/EIf-1	NULL
,	NULL
Elf-1	NULL
,	NULL
or	NULL
MSV	NULL
oligonucleotide	NULL
probes	NULL
with	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
MLA-144	NULL
nuclear	NULL
protein	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
antisera	NULL
.	NULL

Various	NULL
antisera	NULL
,	NULL
as	NULL
noted	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
nuclear	NULL
proteins	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Lanes	NULL
1-7	NULL
were	NULL
run	NULL
on	NULL
one	NULL
gel	NULL
while	NULL
lanes	NULL
8-11	NULL
were	NULL
run	NULL
on	NULL
a	NULL
separate	NULL
gel	NULL
.	NULL

The	NULL
complex	NULL
corresponding	NULL
to	NULL
full-length	NULL
Elf1	NULL
(	NULL
£-Elf-1	NULL
)	NULL
is	NULL
denoted	NULL
by	NULL
a	NULL
closed	NULL
arrow	NULL
as	NULL
well	NULL
as	NULL
the	NULL
supershifted	NULL
complexes	NULL
{	NULL
open	NULL
arrows	NULL
)	NULL
evident	NULL
in	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
11	NULL
.	NULL

Preimmune	NULL
sera	NULL
and	NULL
anti-IL-2	NULL
receptor	NULL
(	NULL
IL	NULL
2R	NULL
)	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

the	NULL
band	NULL
observed	NULL
in	NULL
EMSA	NULL
reactions	NULL
containing	NULL
in	NULL
vitro	NULL
,	NULL
translated	NULL
full-length	NULL
ElK-1	NULL
protein	NULL
and	NULL
the	NULL
AP-1/Elf-1	NULL
probe	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
faint	NULL
supershifted	NULL
complex	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
reactions	NULL
containing	NULL
either	NULL
DNA	NULL
probe	NULL
with	NULL
unstimulated	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
in	NULL
reactions	NULL
with	NULL
the	NULL
AP-1/EIlf-1	NULL
probe	NULL
and	NULL
stimulated	NULL
extracts	NULL
(	NULL
compare	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
IL-2R	NULL
antibody	NULL
or	NULL
preimmune	NULL
serum	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
binding	NULL
activities	NULL
observed	NULL
with	NULL
either	NULL
probe	NULL
or	NULL
with	NULL
either	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
specific	NULL
band	NULL
with	NULL
the	NULL
lowest	NULL
mobility	NULL
observed	NULL
with	NULL
both	NULL
probes	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
was	NULL
unaffected	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
Elf-1	NULL
antiserum	NULL
.	NULL

However	NULL
,	NULL
the	NULL
binding	NULL
activity	NULL
appeared	NULL
to	NULL
be	NULL
greater	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
with	NULL
Elf-1	NULL
probe	NULL
)	NULL
.	NULL

This	NULL
band	NULL
was	NULL
also	NULL
present	NULL
when	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
PEER	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
Clone	NULL
13	NULL
B	NULL
cells	NULL
were	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
EMSA	NULL
data	NULL
demonstrate	NULL
that	NULL
ML	NULL
A-144	NULL
T	NULL
cells	NULL
contain	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nucleotide	NULL
sequences	NULL
,	NULL
that	NULL
Elf-1	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
Elf-1	NULL
nucleotide	NULL
sequences	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
that	NULL
Elf-1	NULL
and	NULL
Jun	NULL
antisera	NULL
block	NULL
proteins	NULL
or	NULL
protein	NULL
complexes	NULL
within	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
two	NULL
sites	NULL
.	NULL

Intact	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
Nuclear	NULL
Protein	NULL
Binding	NULL
Sites	NULL
Are	NULL
Required	NULL
for	NULL
Full	NULL
Functional	NULL
Activity	NULL
.	NULL

We	NULL
next	NULL
asked	NULL
whether	NULL
1687	NULL
Gottschalk	NULL
et	NULL
al	NULL
.	NULL

the	NULL
NF-IL-3	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Elf-1	NULL
sites	NULL
that	NULL
bound	NULL
nuclear	NULL
proteins	NULL
played	NULL
important	NULL
functional	NULL
roles	NULL
in	NULL
IL-3	NULL
gene	NULL
transcriptional	NULL
activation	NULL
in	NULL
intact	NULL
MLA-144	NULL
cells	NULL
.	NULL

A	NULL
series	NULL
of	NULL
mutant	NULL
IL-3	NULL
promoter	NULL
constructs	NULL
were	NULL
produced	NULL
and	NULL
tested	NULL
for	NULL
transcriptional	NULL
activity	NULL
after	NULL
transfection	NULL
into	NULL
MLA-144	NULL
cells	NULL
.	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
-319-bp	NULL
promoter	NULL
in	NULL
the	NULL
AP-1	NULL
,	NULL
the	NULL
Elf-1	NULL
,	NULL
the	NULL
NF-IL-3	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
or	NULL
in	NULL
a	NULL
combination	NULL
of	NULL
sites	NULL
(	NULL
changes	NULL
noted	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
in	NULL
the	NULL
figure	NULL
legend	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
constructs	NULL
containing	NULL
multimerized	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
sites	NULL
with	NULL
intervening	NULL
nucleotides	NULL
were	NULL
cloned	NULL
into	NULL
a	NULL
vector	NULL
under	NULL
the	NULL
direction	NULL
of	NULL
the	NULL
minimal	NULL
SV	NULL
40	NULL
promoter	NULL
and	NULL
tested	NULL
for	NULL
transcriptional	NULL
activity	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
shows	NULL
that	NULL
the	NULL
AP-1	NULL
and	NULL
the	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
necessary	NULL
for	NULL
full	NULL
activity	NULL
in	NULL
stimulated	NULL
MLA-144	NULL
cells	NULL
both	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
endogenous	NULL
IL-3	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
)	NULL
and	NULL
in	NULL
constructs	NULL
containing	NULL
the	NULL
multimerized	NULL
DNA	NULL
segments	NULL
controlled	NULL
by	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NF-IL-3	NULL
site	NULL
in	NULL
-319CAT	NULL
reduced	NULL
CAT	NULL
activity	NULL
by	NULL
80	NULL
%	NULL
,	NULL
demonstrating	NULL
a	NULL
role	NULL
for	NULL
this	NULL
site	NULL
as	NULL
well	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
reduced	NULL
CAT	NULL
activity	NULL
produced	NULL
by	NULL
-319CAT	NULL
with	NULL
the	NULL
NF-IL-3	NULL
mutation	NULL
in	NULL
comparison	NULL
to	NULL
that	NULL
produced	NULL
by	NULL
the	NULL
wild-type	NULL
construct	NULL
is	NULL
less	NULL
dramatic	NULL
when	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
studies	NULL
detailed	NULL
above	NULL
demonstrate	NULL
the	NULL
requirement	NULL
of	NULL
intact	NULL
AP-1	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
NF-IL-3	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
for	NULL
inducible	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

Human	NULL
T	NULL
Cells	NULL
Contain	NULL
Multiple	NULL
Inducible	NULL
Specific	NULL
Nuclear	NULL
Proteins	NULL
That	NULL
Bind	NULL
to	NULL
DNA	NULL
Sequences	NULL
in	NULL
the	NULL
IL-3	NULL
Promoter	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
interaction	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
nuclear	NULL
proteins	NULL
with	NULL
the	NULL
49-bp	NULL
IL-3	NULL
promoter	NULL
sequence	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
using	NULL
various	NULL
oligonucleotide	NULL
probes	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
uninduced	NULL
and	NULL
induced	NULL
,	NULL
purified	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Before	NULL
extract	NULL
preparation	NULL
,	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cells	NULL
was	NULL
stimulated	NULL
for	NULL
6-8	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
which	NULL
induces	NULL
high	NULL
levels	NULL
of	NULL
IL-3	NULL
transcripts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

8	NULL
A	NULL
shows	NULL
that	NULL
multiple	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
induced	NULL
T	NULL
cell	NULL
extracts	NULL
and	NULL
both	NULL
the	NULL
AP-1/EIlf-1	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
arrows	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
DNA	NULL
probes	NULL
(	NULL
lane	NULL
4	NULL
,	NULL
arrows	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
EMSA	NULL
analysis	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
MLA-144	NULL
cells	NULL
,	NULL
very	NULL
little	NULL
complex	NULL
formation	NULL
is	NULL
evident	NULL
using	NULL
uninduced	NULL
human	NULL
T	NULL
cell	NULL
extracts	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
results	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
ML	NULL
A-144	NULL
cells	NULL
,	NULL
the	NULL
band	NULL
pattern	NULL
seen	NULL
with	NULL
human	NULL
T	NULL
cell	NULL
extracts	NULL
and	NULL
the	NULL
AP-1/Elf-1	NULL
probe	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
pattern	NULL
observed	NULL
with	NULL
these	NULL
extracts	NULL
and	NULL
the	NULL
AP-1	NULL
probe	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
is	NULL
distinct	NULL
,	NULL
with	NULL
fewer	NULL
and	NULL
less	NULL
intense	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
AP-1	NULL
probe	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
of	NULL
induced	NULL
T	NULL
cell	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
AP-1/EIlf-1	NULL
DNA	NULL
subfragment	NULL
was	NULL
assessed	NULL
using	NULL
unlabeled	NULL
DNA	NULL
competitors	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
.	NULL

The	NULL
two	NULL
higher	NULL
mobility	NULL
bands	NULL
denoted	NULL
by	NULL
closed	NULL
arrows	NULL
were	NULL
specific	NULL
as	NULL
demonstrated	NULL
by	NULL
competition	NULL
with	NULL
wild-type	NULL
competitor	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
unrelated	NULL
competitor	NULL
(	NULL
MNIP	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
mutated	NULL
competitor	NULL
(	NULL
MElf-1	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Clearly	NULL
,	NULL
the	NULL
lowest	NULL
mobility	NULL
band	NULL
denoted	NULL
by	NULL
a	NULL
closed	NULL
arrow	NULL
is	NULL
nonspecific	NULL
because	NULL
it	NULL
is	NULL
competed	NULL
by	NULL
both	NULL
specific	NULL
and	NULL
lL-Gfiomolorjgrﬂgﬁfr_	NULL
|	NULL
cat	NULL
ii—	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
(	NULL
%	NULL
)	NULL
25	NULL
50	NULL
75	NULL
100	NULL
}	NULL
®-C-+	NULL
co-	NULL
pg-C-+	NULL
B	NULL
.	NULL

Puk	NULL
Pik	NULL
.	NULL

CA	NULL
Avery	NULL
+	NULL
54	NULL
--	NULL
|	NULL
361	NULL
.	NULL

meB	NULL
$	NULL
__	NULL
.	NULL

-	NULL
4	NULL
--	NULL
Sx	NULL
mart	NULL
»	NULL
meds	NULL
|	NULL
svace	NULL
[	NULL
``	NULL
Car	NULL
)	NULL
+	NULL
2	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
Functional	NULL
analysis	NULL
of	NULL
three	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
.	NULL

MLA-144	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
CAT	NULL
construct	NULL
under	NULL
the	NULL
control	NULL
of	NULL
319	NULL
bp	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
promoter	NULL
(	NULL
A	NULL
)	NULL
or	NULL
with	NULL
a	NULL
CAT	NULL
construct	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
AP-1/EIf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
found	NULL
in	NULL
human	NULL
IL-3	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
B	NULL
)	NULL
.	NULL

CAT	NULL
constructs	NULL
with	NULL
mutations	NULL
in	NULL
up	NULL
to	NULL
three	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
were	NULL
also	NULL
tested	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
pRSV	NULL
Agal	NULL
was	NULL
included	NULL
in	NULL
each	NULL
transfection	NULL
to	NULL
normalize	NULL
efficien-cies	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
groups	NULL
:	NULL
one	NULL
that	NULL
received	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
and	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
8	NULL
h	NULL
before	NULL
harvest	NULL
and	NULL
a	NULL
second	NULL
group	NULL
that	NULL
was	NULL
incubated	NULL
with	NULL
media	NULL
only	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Activity	NULL
of	NULL
constructs	NULL
containing	NULL
mutated	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
endogenous	NULL
IL-3	NULL
promoter	NULL
.	NULL

The	NULL
mutations	NULL
were	NULL
(	NULL
AP-1	NULL
)	NULL
TGAGTCAG	NULL
to	NULL
TCTCGAGC	NULL
,	NULL
(	NULL
ElF-1	NULL
)	NULL
GGCAGGAAGGG	NULL
to	NULL
TGTCTCCTTCG	NULL
,	NULL
and	NULL
(	NULL
NF-IL-3	NULL
)	NULL
ATGAA-TAA	NULL
to	NULL
GACTCGAG	NULL
.	NULL

Activity	NULL
shown	NULL
is	NULL
that	NULL
of	NULL
stimulated	NULL
ML	NULL
A-144	NULL
cells	NULL
only	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
is	NULL
that	NULL
given	NULL
each	NULL
construct	NULL
compared	NULL
to	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
the	NULL
pCAT	NULL
vector	NULL
alone	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
transfected	NULL
at	NULL
least	NULL
three	NULL
times	NULL
and	NULL
the	NULL
data	NULL
shown	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activity	NULL
of	NULL
intact	NULL
and	NULL
mutant	NULL
multimerized	NULL
AP-1/EIf1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
constructs	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
heterologous	NULL
minimal	NULL
SV40	NULL
promoter	NULL
.	NULL

The	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
AP-1	NULL
site	NULL
were	NULL
identical	NULL
to	NULL
A	NULL
.	NULL

The	NULL
EIf1	NULL
site	NULL
in	NULL
this	NULL
construct	NULL
was	NULL
mutated	NULL
to	NULL
TGTCTGCTGCC	NULL
.	NULL

Cultures	NULL
stimulated	NULL
with	NULL
PHA/PMA	NULL
are	NULL
denoted	NULL
by	NULL
{	NULL
+	NULL
)	NULL
.	NULL

Relative	NULL
CAT	NULL
activity	NULL
here	NULL
represents	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
the	NULL
individual	NULL
construct	NULL
in	NULL
extracts	NULL
from	NULL
induced	NULL
cultures	NULL
compared	NULL
to	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
the	NULL
construct	NULL
in	NULL
extracts	NULL
from	NULL
uninduced	NULL
cultures	NULL
.	NULL

The	NULL
uninduced	NULL
and	NULL
induced	NULL
samples	NULL
were	NULL
assayed	NULL
on	NULL
the	NULL
same	NULL
day	NULL
but	NULL
run	NULL
on	NULL
two	NULL
thin	NULL
layer	NULL
chromatographic	NULL
plates	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
transfected	NULL
three	NULL
times	NULL
with	NULL
different	NULL
preparations	NULL
of	NULL
plasmid	NULL
DNA	NULL
and	NULL
the	NULL
data	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
one	NULL
experiment	NULL
.	NULL

nonspecific	NULL
competitors	NULL
.	NULL

The	NULL
competitions	NULL
observed	NULL
using	NULL
unlabeled	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
DNA	NULL
probes	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
pattern	NULL
seen	NULL
with	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
because	NULL
(	NULL
a	NULL
)	NULL
at	NULL
least	NULL
one	NULL
complex	NULL
is	NULL
evident	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competitor	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
open	NULL
arrow	NULL
)	NULL
and	NULL
this	NULL
band	NULL
runs	NULL
A	NULL
.	NULL

B	NULL
a	NULL
vor	NULL
e	NULL
&	NULL
&	NULL
i	NULL
dos	NULL
Z	NULL
w	NULL
Competitor	NULL
:	NULL
'	NULL
#	NULL
%	NULL
|	NULL
§	NULL
&	NULL
_	NULL
'	NULL
_	NULL
--	NULL
-	NULL
ia	NULL
a	NULL
E	NULL
#	NULL
E	NULL
Extract	NULL
:	NULL
-	NULL
Human	NULL
T	NULL
Cells-Stim	NULL
is	NULL
Extract	NULL
-	NULL
5	NULL
&	NULL
5	NULL
&	NULL
_	NULL
>	NULL
-p	NULL
4-1	NULL
)	NULL
»	NULL
.	NULL

-=	NULL
#	NULL
<	NULL
€mm-	NULL
«	NULL
-	NULL
10	NULL
20	NULL
3	NULL
4	NULL
L_	NULL
L__I	NULL
Probe	NULL
:	NULL
AP-1/Eif-1	NULL
AP-1	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Probe	NULL
:	NULL
AP-1/Elf-1	NULL
Figure	NULL
8	NULL
.	NULL

EMSA	NULL
using	NULL
radiolabeled	NULL
AP-1/EIf-1	NULL
and	NULL
AP-1	NULL
oligonucleotide	NULL
probes	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
human	NULL
T	NULL
cells	NULL
purified	NULL
by	NULL
elutriation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
AP-1/Elf-1	NULL
or	NULL
AP-1	NULL
DNA	NULL
probes	NULL
with	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
human	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Complexes	NULL
formed	NULL
by	NULL
nuclear	NULL
proteins	NULL
and	NULL
the	NULL
AP-1/EIf-1	NULL
probe	NULL
are	NULL
denoted	NULL
by	NULL
closed	NULL
arrows	NULL
,	NULL
whereas	NULL
complexes	NULL
formed	NULL
by	NULL
nuclear	NULL
proteins	NULL
and	NULL
the	NULL
AP-1	NULL
probe	NULL
are	NULL
denoted	NULL
by	NULL
open	NULL
arrows	NULL
.	NULL

The	NULL
panels	NULL
depicting	NULL
analyses	NULL
with	NULL
the	NULL
AP-1/EIf-1	NULL
probe	NULL
and	NULL
the	NULL
AP-1	NULL
probe	NULL
represent	NULL
gels	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
identical	NULL
timepoints	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
using	NULL
a	NULL
radiolabeled	NULL
AP-1/Elf-1	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200	NULL
ng	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
competitors	NULL
as	NULL
marked	NULL
.	NULL

with	NULL
similar	NULL
mobility	NULL
to	NULL
the	NULL
band	NULL
formed	NULL
with	NULL
the	NULL
same	NULL
probe	NULL
and	NULL
in	NULL
vitro-translated	NULL
full-length	NULL
Elf-1	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
demonstrate	NULL
diminution	NULL
of	NULL
the	NULL
highest	NULL
mobility	NULL
band	NULL
denoted	NULL
by	NULL
a	NULL
closed	NULL
arrow	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Elf-1	NULL
DNA	NULL
competitor	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
are	NULL
two	NULL
bands	NULL
that	NULL
run	NULL
with	NULL
similar	NULL
mobility	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
lowest	NULL
mobility	NULL
specific	NULL
band	NULL
observed	NULL
in	NULL
EMSA	NULL
reactions	NULL
with	NULL
the	NULL
MLA-144	NULL
nuclear	NULL
extracts	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
present	NULL
in	NULL
EMSA	NULL
reactions	NULL
conducted	NULL
with	NULL
human	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Discussion	NULL
IL-3	NULL
is	NULL
a	NULL
potent	NULL
inducible	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
that	NULL
is	NULL
produced	NULL
solely	NULL
by	NULL
activated	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
multiple	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
T	NULL
cell-restricted	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
,	NULL
including	NULL
sites	NULL
that	NULL
bind	NULL
to	NULL
AP-1	NULL
transcription	NULL
factors	NULL
and	NULL
to	NULL
Elf-1	NULL
,	NULL
an	NULL
Ets	NULL
family	NULL
transcription	NULL
factor	NULL
.	NULL

With	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
by	NULL
direct	NULL
binding	NULL
and	NULL
competition	NULL
that	NULL
these	NULL
sites	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
bind	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
DNA	NULL
subfragment	NULL
containing	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
,	NULL
CAT	NULL
constructs	NULL
including	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
IL-3	NULL
promoter/enhancer	NULL
were	NULL
active	NULL
in	NULL
both	NULL
T	NULL
and	NULL
non-T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mutation	NULL
of	NULL
an	NULL
element	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
restricting	NULL
IL-3	NULL
expression	NULL
,	NULL
NIP	NULL
,	NULL
failed	NULL
to	NULL
1688	NULL
Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
increase	NULL
transcription	NULL
to	NULL
the	NULL
level	NULL
seen	NULL
with	NULL
a	NULL
smaller	NULL
subfragment	NULL
when	NULL
transfected	NULL
into	NULL
activated	NULL
T	NULL
and	NULL
non-T	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
AP-1/	NULL
Elf-1	NULL
cassette	NULL
is	NULL
critical	NULL
to	NULL
cell-restricted	NULL
and	NULL
inducible	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
were	NULL
found	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
IL-3	NULL
gene	NULL
expression	NULL
,	NULL
because	NULL
constructs	NULL
with	NULL
these	NULL
sites	NULL
deleted	NULL
were	NULL
inactive	NULL
in	NULL
induced	NULL
T	NULL
cells	NULL
.	NULL

DNasel	NULL
footprint	NULL
and	NULL
EMSA	NULL
analyses	NULL
revealed	NULL
that	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
intervening	NULL
DNA	NULL
bound	NULL
multiple	NULL
specific	NULL
nuclear	NULL
protein	NULL
complexes	NULL
,	NULL
and	NULL
there	NULL
were	NULL
differences	NULL
in	NULL
the	NULL
mobilities	NULL
but	NULL
not	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
complexes	NULL
observed	NULL
in	NULL
EMSAs	NULL
using	NULL
extracts	NULL
from	NULL
resting	NULL
or	NULL
induced	NULL
MLA-144	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
there	NULL
may	NULL
be	NULL
distinct	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
IL-3	NULL
promoter	NULL
in	NULL
induced	NULL
and	NULL
uninduced	NULL
extracts	NULL
,	NULL
or	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
proteins	NULL
might	NULL
undergo	NULL
posttranslational	NULL
modifications	NULL
after	NULL
ac-tivation	NULL
,	NULL
or	NULL
that	NULL
different	NULL
protein-protein	NULL
interactions	NULL
may	NULL
exist	NULL
in	NULL
resting	NULL
and	NULL
induced	NULL
cells	NULL
.	NULL

Further	NULL
studies	NULL
with	NULL
antisera	NULL
revealed	NULL
that	NULL
both	NULL
Elf-1	NULL
and	NULL
Jun	NULL
family	NULL
binding	NULL
proteins	NULL
individually	NULL
formed	NULL
complexes	NULL
with	NULL
the	NULL
AP-1/Elf-1	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
proteins	NULL
that	NULL
were	NULL
blocked	NULL
by	NULL
Jun	NULL
family	NULL
antiserum	NULL
in	NULL
extracts	NULL
from	NULL
resting	NULL
MLA-144	NULL
cells	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
constitutive	NULL
expression	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
family	NULL
proteins	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Evidence	NULL
for	NULL
high	NULL
constitutive	NULL
expression	NULL
of	NULL
JunD	NULL
,	NULL
and	NULL
low	NULL
but	NULL
detectable	NULL
expression	NULL
of	NULL
Jun-B	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
Fra-1	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
other	NULL
resting	NULL
cells	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
distinct	NULL
combinations	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
IL-3	NULL
gene	NULL
during	NULL
different	NULL
stages	NULL
of	NULL
activation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Because	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
protein-protein	NULL
interactions	NULL
between	NULL
the	NULL
various	NULL
Jun	NULL
and	NULL
Fos	NULL
transcription	NULL
factors	NULL
mediate	NULL
the	NULL
differential	NULL
effects	NULL
observed	NULL
in	NULL
regulation	NULL
of	NULL
AP-1	NULL
proteins	NULL
(	NULL
30	NULL
)	NULL
,	NULL
examination	NULL
of	NULL
the	NULL
individual	NULL
constituents	NULL
of	NULL
the	NULL
Fos/Jun	NULL
or	NULL
Jun/Jun	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
IL-3	NULL
gene	NULL
AP-1	NULL
site	NULL
in	NULL
uninduced	NULL
or	NULL
induced	NULL
MLA-144	NULL
T	NULL
cells	NULL
will	NULL
be	NULL
important	NULL
to	NULL
elucidate	NULL
.	NULL

Finally	NULL
,	NULL
EMSA	NULL
studies	NULL
using	NULL
purified	NULL
human	NULL
T	NULL
cells	NULL
demonstrated	NULL
that	NULL
binding	NULL
activities	NULL
were	NULL
largely	NULL
limited	NULL
to	NULL
extracts	NULL
prepared	NULL
from	NULL
induced	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
is	NULL
not	NULL
unexpected	NULL
,	NULL
and	NULL
the	NULL
demonstration	NULL
of	NULL
binding	NULL
activities	NULL
in	NULL
unstimulated	NULL
MLA-144	NULL
cell	NULL
extracts	NULL
possibly	NULL
reflects	NULL
the	NULL
transformed	NULL
state	NULL
of	NULL
the	NULL
ML	NULL
A-144	NULL
cells	NULL
.	NULL

The	NULL
exact	NULL
DNA	NULL
composition	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
Ets	NULL
family	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
flanking	NULL
DNA	NULL
sequences	NULL
,	NULL
and	NULL
the	NULL
distance	NULL
between	NULL
these	NULL
sites	NULL
may	NULL
determine	NULL
the	NULL
fine	NULL
specificity	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Ets	NULL
protooncogene	NULL
family	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
purine-rich	NULL
DNA	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
several	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
26	NULL
,	NULL
33	NULL
,	NULL
38	NULL
,	NULL
40	NULL
,	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
core	NULL
GGA	NULL
sequences	NULL
are	NULL
absolutely	NULL
required	NULL
for	NULL
DNA-protein	NULL
interaction	NULL
,	NULL
whereas	NULL
the	NULL
flanking	NULL
sequences	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
different	NULL
Ets	NULL
family	NULL
members	NULL
(	NULL
39	NULL
)	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
the	NULL
IL-3	NULL
gene	NULL
,	NULL
examination	NULL
of	NULL
the	NULL
EBS	NULL
sequence	NULL
predicts	NULL
that	NULL
the	NULL
IL-3	NULL
gene	NULL
can	NULL
bind	NULL
Elf-1	NULL
because	NULL
of	NULL
a	NULL
permissive	NULL
A	NULL
at	NULL
nucleotide	NULL
8	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Whether	NULL
an	NULL
Ets	NULL
family	NULL
transcriptional	NULL
protein	NULL
actually	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
AP-1	NULL
dimers	NULL
or	NULL
a	NULL
third	NULL
protein	NULL
bridge	NULL
may	NULL
depend	NULL
on	NULL
the	NULL
distance	NULL
separating	NULL
the	NULL
two	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Boise	NULL
et	NULL
al	NULL
.	NULL

1689	NULL
Gottschalk	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
NFAT	NULL
complex	NULL
formation	NULL
requires	NULL
cooperation	NULL
between	NULL
an	NULL
Ets	NULL
family	NULL
factor	NULL
and	NULL
AP-1	NULL
dimers	NULL
,	NULL
and	NULL
the	NULL
EBS	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
NFAT	NULL
motif	NULL
are	NULL
1	NULL
bp	NULL
apart	NULL
.	NULL

Likewise	NULL
,	NULL
Wasylyk	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
demonstrate	NULL
that	NULL
the	NULL
ets-1	NULL
protein	NULL
interacts	NULL
with	NULL
AP-1	NULL
dimers	NULL
to	NULL
activate	NULL
transcription	NULL
through	NULL
the	NULL
PEA3	NULL
motif	NULL
in	NULL
the	NULL
polyoma	NULL
enhancer	NULL
.	NULL

In	NULL
the	NULL
oncogene-responsive	NULL
domain	NULL
of	NULL
the	NULL
polyoma	NULL
enhancer	NULL
,	NULL
the	NULL
ets-1	NULL
and	NULL
AP-1	NULL
sites	NULL
overlap	NULL
by	NULL
several	NULL
bases	NULL
,	NULL
and	NULL
analyses	NULL
using	NULL
chimeric	NULL
constructs	NULL
revealed	NULL
that	NULL
maximal	NULL
levels	NULL
of	NULL
activity	NULL
were	NULL
possible	NULL
only	NULL
when	NULL
these	NULL
sites	NULL
were	NULL
adjacent	NULL
(	NULL
48	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IL-3	NULL
gene	NULL
are	NULL
separated	NULL
by	NULL
six	NULL
nucleotides	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
spatial	NULL
orientation	NULL
may	NULL
account	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
these	NULL
sites	NULL
can	NULL
bind	NULL
to	NULL
some	NULL
proteins	NULL
or	NULL
protein	NULL
complexes	NULL
independently	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
demonstrated	NULL
the	NULL
critical	NULL
importance	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
sequences	NULL
to	NULL
inducible	NULL
,	NULL
T	NULL
cell-restricted	NULL
IL-3	NULL
gene	NULL
expression	NULL
,	NULL
both	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
transcription	NULL
factors	NULL
themselves	NULL
are	NULL
found	NULL
in	NULL
non-T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

There-fore	NULL
,	NULL
the	NULL
manner	NULL
in	NULL
which	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
proteins	NULL
might	NULL
confer	NULL
T	NULL
cell	NULL
IL-3	NULL
specificity	NULL
is	NULL
of	NULL
extreme	NULL
interest	NULL
including	NULL
several	NULL
possibilities	NULL
.	NULL

First	NULL
,	NULL
T	NULL
cell-specific	NULL
proteins	NULL
may	NULL
interact	NULL
with	NULL
the	NULL
AP-1	NULL
or	NULL
Elf-1	NULL
binding	NULL
factors	NULL
but	NULL
not	NULL
directly	NULL
with	NULL
DNA	NULL
.	NULL

Second	NULL
,	NULL
there	NULL
may	NULL
be	NULL
yet	NULL
undefined	NULL
regulatory	NULL
protein	NULL
binding	NULL
sites	NULL
and	NULL
binding	NULL
factors	NULL
not	NULL
detected	NULL
by	NULL
DNasel	NULL
and	NULL
EMSA	NULL
analyses	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
transcription	NULL
factors	NULL
may	NULL
undergo	NULL
posttranslational	NULL
modification	NULL
in	NULL
vivo	NULL
leading	NULL
to	NULL
T	NULL
cell-restricted	NULL
gene	NULL
expression	NULL
.	NULL

Previous	NULL
investigators	NULL
have	NULL
suggested	NULL
that	NULL
two	NULL
different	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
the	NULL
NF-IL-3	NULL
and	NULL
the	NULL
NIP	NULL
sites	NULL
,	NULL
may	NULL
play	NULL
roles	NULL
in	NULL
T	NULL
cell-specific	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Davies	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
implicated	NULL
the	NULL
NF-IL-3	NULL
site	NULL
(	NULL
within	NULL
the	NULL
ACT	NULL
-1	NULL
motif	NULL
)	NULL
in	NULL
IL-3	NULL
expression	NULL
,	NULL
yet	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
this	NULL
site	NULL
is	NULL
only	NULL
evident	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
construct	NULL
truncated	NULL
just	NULL
5°	NULL
to	NULL
the	NULL
NF-IL-3	NULL
site	NULL
.	NULL

Within	NULL
a	NULL
larger	NULL
construct	NULL
(	NULL
300	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
DNA	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
an	NULL
ACT	NULL
-1	NULL
mutation	NULL
is	NULL
negligible	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
NF-IL-3	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
319	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
sequence	NULL
dramatically	NULL
reduces	NULL
CAT	NULL
activity	NULL
as	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
native	NULL
IL-3	NULL
promoter	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possibilities	NULL
for	NULL
this	NULL
discrepancy	NULL
.	NULL

First	NULL
,	NULL
the	NULL
designs	NULL
of	NULL
mutant	NULL
constructs	NULL
were	NULL
different	NULL
.	NULL

We	NULL
mutated	NULL
specific	NULL
bases	NULL
within	NULL
the	NULL
NF-IL-3	NULL
site	NULL
,	NULL
whereas	NULL
Davies	NULL
replaced	NULL
the	NULL
entire	NULL
NF-IL-3	NULL
site	NULL
and	NULL
the	NULL
3	NULL
'	NULL
CRE	NULL
element	NULL
with	NULL
a	NULL
short	NULL
DNA	NULL
spacer	NULL
(	NULL
15	NULL
to	NULL
6	NULL
bp	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
latter	NULL
construct	NULL
the	NULL
spatial	NULL
interactions	NULL
were	NULL
dramatically	NULL
altered	NULL
and	NULL
the	NULL
NF-IL-3	NULL
site	NULL
mutations	NULL
were	NULL
not	NULL
isolated	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
when	NULL
we	NULL
tested	NULL
a	NULL
construct	NULL
truncated	NULL
immediately	NULL
3	NULL
'	NULL
of	NULL
the	NULL
NF-IL-3	NULL
site	NULL
,	NULL
-150CAT	NULL
(	NULL
including	NULL
the	NULL
CRE	NULL
or	NULL
3	NULL
'	NULL
section	NULL
of	NULL
ACT	NULL
-1	NULL
)	NULL
,	NULL
this	NULL
construct	NULL
gave	NULL
50-100	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
given	NULL
by	NULL
the	NULL
larger	NULL
-175CAT	NULL
construct	NULL
.	NULL

Thus	NULL
,	NULL
Davies	NULL
'	NULL
deletion	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
impact	NULL
greatly	NULL
on	NULL
transcriptional	NULL
activity	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
modes	NULL
of	NULL
IL-3	NULL
gene	NULL
induction	NULL
in	NULL
the	NULL
transfected	NULL
MLA-144	NULL
cells	NULL
were	NULL
different	NULL
.	NULL

We	NULL
induced	NULL
IL-3	NULL
gene	NULL
expression	NULL
in	NULL
MLA-144	NULL
cells	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
whereas	NULL
Davies	NULL
et	NULL
al	NULL
.	NULL

activated	NULL
these	NULL
cells	NULL
with	NULL
PMA	NULL
alone	NULL
.	NULL

Our	NULL
Northern	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
IL-3	NULL
transcripts	NULL
in	NULL
MLA-144	NULL
cells	NULL
are	NULL
significantly	NULL
lower	NULL
following	NULL
incubation	NULL
with	NULL
PMA	NULL
in	NULL
con	NULL
trast	NULL
to	NULL
the	NULL
levels	NULL
shown	NULL
with	NULL
PHA/PMA	NULL
stimulation	NULL
.	NULL

There-fore	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
larger	NULL
construct	NULL
described	NULL
in	NULL
the	NULL
other	NULL
report	NULL
(	NULL
21	NULL
)	NULL
may	NULL
not	NULL
be	NULL
evident	NULL
during	NULL
low-level	NULL
IL-3	NULL
gene	NULL
transcription	NULL
.	NULL

Interestingly	NULL
,	NULL
our	NULL
construct	NULL
with	NULL
NF-IL-3	NULL
site	NULL
mutations	NULL
which	NULL
produced	NULL
significantly	NULL
less	NULL
CAT	NULL
activity	NULL
compared	NULL
to	NULL
wild-type	NULL
constructs	NULL
after	NULL
transfection	NULL
into	NULL
MLA-144	NULL
T	NULL
cells	NULL
,	NULL
reduced	NULL
CAT	NULL
activity	NULL
only	NULL
moderately	NULL
when	NULL
tested	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
data	NULL
derived	NULL
from	NULL
experiments	NULL
using	NULL
Jurkat	NULL
cells	NULL
must	NULL
be	NULL
carefully	NULL
assessed	NULL
because	NULL
these	NULL
cells	NULL
produce	NULL
extremely	NULL
low	NULL
levels	NULL
of	NULL
IL-3	NULL
.	NULL

Two	NULL
groups	NULL
have	NULL
suggested	NULL
that	NULL
this	NULL
lineage-restricted	NULL
expression	NULL
is	NULL
primarily	NULL
regulated	NULL
by	NULL
the	NULL
NIP	NULL
element	NULL
in	NULL
the	NULL
IL-3	NULL
promoter	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NIP	NULL
sequence	NULL
in	NULL
the	NULL
context	NULL
of	NULL
-270CAT	NULL
failed	NULL
to	NULL
increase	NULL
CAT	NULL
activity	NULL
to	NULL
the	NULL
level	NULL
observed	NULL
with	NULL
the	NULL
smaller	NULL
-175CAT	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
another	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
addition	NULL
to	NULL
or	NULL
instead	NULL
of	NULL
NIP	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
repressing	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

Alternatively	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
upstream	NULL
sequences	NULL
,	NULL
NIP	NULL
mutations	NULL
are	NULL
unable	NULL
to	NULL
restore	NULL
CAT	NULL
activity	NULL
to	NULL
the	NULL
levels	NULL
observed	NULL
with	NULL
-150CAT	NULL
and	NULL
-175CAT	NULL
.	NULL

In	NULL
any	NULL
event	NULL
,	NULL
our	NULL
data	NULL
do	NULL
not	NULL
support	NULL
a	NULL
major	NULL
role	NULL
for	NULL
the	NULL
NIP	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
cell	NULL
specificity	NULL
of	NULL
IL-3	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
that	NULL
produce	NULL
significant	NULL
quantities	NULL
of	NULL
IL-3	NULL
mRNA	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
of	NULL
particular	NULL
interest	NULL
in	NULL
light	NULL
of	NULL
recent	NULL
studies	NULL
on	NULL
both	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
and	NULL
T	NULL
cell	NULL
cytokine	NULL
deficiency	NULL
after	NULL
bone	NULL
marrow	NULL
transplantation	NULL
.	NULL

Schwartz	NULL
and	NULL
Kong	NULL
et	NULL
al	NULL
.	NULL

(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
have	NULL
found	NULL
that	NULL
antigen-specific	NULL
anergic	NULL
T	NULL
cell	NULL
clones	NULL
display	NULL
profound	NULL
deficiencies	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
transcription	NULL
factors	NULL
to	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

Similar	NULL
AP-1	NULL
nuclear	NULL
protein	NULL
deficiencies	NULL
could	NULL
well	NULL
explain	NULL
the	NULL
T	NULL
cell	NULL
anergy	NULL
routinely	NULL
observed	NULL
following	NULL
bone	NULL
marrow	NULL
transplantation	NULL
in	NULL
which	NULL
T	NULL
cells	NULL
arising	NULL
after	NULL
transplant	NULL
fail	NULL
to	NULL
secrete	NULL
either	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
in	NULL
response	NULL
to	NULL
mitogens	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
AP-1	NULL
and	NULL
EBS	NULL
nuclear	NULL
binding	NULL
proteins	NULL
may	NULL
be	NULL
a	NULL
major	NULL
molecular	NULL
checkpoint	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
developmental	NULL
program	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
diverse	NULL
clinical	NULL
settings	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
5	NULL
``	NULL
flanking	NULL
sequences	NULL
containing	NULL
nonadjacent	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
conferring	NULL
T	NULL
cell	NULL
specificity	NULL
to	NULL
IL-3	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
NF-IL-3	NULL
and	NULL
NIP	NULL
sites	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
in	NULL
reporter	NULL
constructs	NULL
with	NULL
flanking	NULL
IL-3	NULL
gene	NULL
sequences	NULL
distinguish	NULL
T	NULL
cells	NULL
from	NULL
non-T	NULL
cells	NULL
and	NULL
are	NULL
most	NULL
evident	NULL
under	NULL
conditions	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
that	NULL
maximally	NULL
stimulate	NULL
IL-3	NULL
production	NULL
per	NULL
se	NULL
.	NULL

Future	NULL
studies	NULL
identifying	NULL
the	NULL
particular	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
,	NULL
as	NULL
well	NULL
as	NULL
additional	NULL
proteins	NULL
involved	NULL
in	NULL
activation	NULL
at	NULL
the	NULL
AP-1	NULL
and	NULL
EIf-1	NULL
sites	NULL
will	NULL
be	NULL
extremely	NULL
interestingly	NULL
in	NULL
illuminating	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
T	NULL
cell	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
authors	NULL
wish	NULL
to	NULL
thank	NULL
Rodrigo	NULL
Bravo	NULL
for	NULL
Jun	NULL
family	NULL
antiserum	NULL
,	NULL
Beverly	NULL
Prenevost	NULL
for	NULL
tireless	NULL
figure	NULL
preparation	NULL
,	NULL
and	NULL
Michael	NULL
Parmacek	NULL
,	NULL
Lawrence	NULL
Boise	NULL
,	NULL
and	NULL
Jeffrey	NULL
Leiden	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
advice	NULL
during	NULL
this	NULL
work	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Diabetes	NULL
,	NULL
Digestive	NULL
and	NULL
Kidney	NULL
Disease	NULL
.	NULL

S.	NULL
Emerson	NULL
is	NULL
a	NULL
Leukemia	NULL
Scholar	NULL
of	NULL
America	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Lisa	NULL
R.	NULL
Gottschalk	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
5841	NULL
S.	NULL
Maryland	NULL
,	NULL
MC5041	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60637	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
3	NULL
May	NULL
1993	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
21	NULL
July	NULL
1993	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Emerson	NULL
,	NULL
SG	NULL
.	NULL

,	NULL
Y.	NULL
Yang	NULL
,	NULL
S.C.	NULL
Clark	NULL
,	NULL
and	NULL
MW	NULL
.	NULL

Long	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
recombinant	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
and	NULL
interleukin	NULL
3	NULL
have	NULL
overlapping	NULL
but	NULL
distinct	NULL
hematopoietic	NULL
activities	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

82:1282	NULL
.	NULL

2	NULL
.	NULL

Spivak	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
R.R.L	NULL
.	NULL

Smith	NULL
,	NULL
and	NULL
J.N	NULL
.	NULL

Ihle	NULL
.	NULL

1985	NULL
.	NULL

Interleukin	NULL
3	NULL
promotes	NULL
the	NULL
in	NULL
vitro	NULL
proliferation	NULL
of	NULL
murine	NULL
pluripotent	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
,	NULL
76:1613	NULL
.	NULL

3	NULL
.	NULL

Lopez	NULL
,	NULL
A.F	NULL
.	NULL

,	NULL
L.B	NULL
.	NULL

To	NULL
,	NULL
Y.	NULL
Yang	NULL
,	NULL
J.R.	NULL
Gamble	NULL
,	NULL
M.F	NULL
.	NULL

Shannon	NULL
,	NULL
G.F.	NULL
Burns	NULL
,	NULL
PG	NULL
.	NULL

Dyson	NULL
,	NULL
C.A	NULL
.	NULL

Juttner	NULL
,	NULL
S.	NULL
Clark	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Vadas	NULL
.	NULL

1987	NULL
.	NULL

Stimulation	NULL
of	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
function	NULL
of	NULL
human	NULL
cells	NULL
by	NULL
primate	NULL
interleukin	NULL
3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:2761	NULL
.	NULL

4	NULL
.	NULL

Bot	NULL
,	NULL
FJ	NULL
.	NULL

,	NULL
L.	NULL
Dorssers	NULL
,	NULL
G.	NULL
Wagemaker	NULL
,	NULL
and	NULL
B.	NULL
Lowenberg	NULL
.	NULL

1988	NULL
.	NULL

Stimulating	NULL
spectrum	NULL
of	NULL
human	NULL
recombinant	NULL
multi-CSF	NULL
(	NULL
IL-3	NULL
)	NULL
on	NULL
human	NULL
marrow	NULL
precursors	NULL
:	NULL
importance	NULL
of	NULL
accessory	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

71:1609	NULL
.	NULL

1690	NULL
5	NULL
.	NULL

Suda	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Suda	NULL
,	NULL
M.	NULL
Ogawa	NULL
,	NULL
and	NULL
J.N	NULL
.	NULL

Ihle	NULL
.	NULL

1985	NULL
.	NULL

Permissive	NULL
role	NULL
of	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
in	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
multipotential	NULL
progenitors	NULL
in	NULL
culture	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

124:182	NULL
.	NULL

6	NULL
.	NULL

Holmes	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
E.	NULL
Palaszynski	NULL
,	NULL
TN	NULL
.	NULL

Frederickson	NULL
,	NULL
H.C.	NULL
Morse	NULL
,	NULL
and	NULL
J.N	NULL
.	NULL

Ihle	NULL
.	NULL

1985	NULL
.	NULL

Correlation	NULL
of	NULL
cell-surface	NULL
phenotype	NULL
with	NULL
the	NULL
establishment	NULL
of	NULL
interleukin	NULL
3-dependent	NULL
cell	NULL
lines	NULL
from	NULL
wild-mouse	NULL
murine	NULL
leukemia	NULL
virus-induced	NULL
neoplasms	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

82:6687	NULL
.	NULL

7	NULL
.	NULL

Bodine	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
S.	NULL
Karlsson	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
.	NULL

1989	NULL
.	NULL

Combination	NULL
of	NULL
interleukins	NULL
3	NULL
and	NULL
6	NULL
preserves	NULL
stem	NULL
cell	NULL
function	NULL
in	NULL
culture	NULL
and	NULL
enhancers	NULL
retrovirus-mediated	NULL
gene	NULL
transfer	NULL
into	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:8897	NULL
.	NULL

8	NULL
.	NULL

Guba	NULL
,	NULL
SC	NULL
.	NULL

,	NULL
G.	NULL
Stella	NULL
,	NULL
L.A.	NULL
Turka	NULL
,	NULL
C.H	NULL
.	NULL

June	NULL
,	NULL
C.B	NULL
.	NULL

Thompson	NULL
,	NULL
and	NULL
S.G.	NULL
Emerson	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin	NULL
3	NULL
gene	NULL
induction	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84:1701	NULL
,	NULL
9	NULL
.	NULL

Niemeyer	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
C.A	NULL
.	NULL

Sieff	NULL
,	NULL
B.	NULL
Mathey-Prevot	NULL
,	NULL
J.S	NULL
.	NULL

Wimperis	NULL
,	NULL
Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

B.E	NULL
.	NULL

Bierer	NULL
,	NULL
S.C.	NULL
Clark	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Nathan	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
interleukin-3	NULL
(	NULL
multi-CSF	NULL
)	NULL
is	NULL
restricted	NULL
to	NULL
human	NULL
lym-phocytes	NULL
and	NULL
T-cell	NULL
tumor	NULL
lines	NULL
.	NULL

Blood	NULL
.	NULL

73:945	NULL
.	NULL

Otsuka	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
N.	NULL
Brown	NULL
,	NULL
K.	NULL
Otsu	NULL
,	NULL
J.	NULL
Abramson	NULL
,	NULL
S.	NULL
Saeland	NULL
,	NULL
C.	NULL
Caux	NULL
,	NULL
R.	NULL
De	NULL
Waal	NULL
Malafijt	NULL
,	NULL
J	NULL
.	NULL

De	NULL
Vries	NULL
,	NULL
P.	NULL
Meyerson	NULL
,	NULL
K.	NULL
Yocota	NULL
,	NULL
L.	NULL
Gemmel	NULL
,	NULL
D.	NULL
Rennik	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
expressible	NULL
cDNA	NULL
encoding	NULL
human	NULL
IL-3	NULL
.	NULL

Induction	NULL
of	NULL
IL-3	NULL
mRNA	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:2288	NULL
.	NULL

Clark	NULL
,	NULL
S.C.	NULL
,	NULL
and	NULL
R.	NULL
Kamen	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
hematopoietic	NULL
colony-stimulating	NULL
factors	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

236:1229	NULL
.	NULL

Sieff	NULL
,	NULL
C.A.S	NULL
.	NULL

,	NULL
S.	NULL
Tsai	NULL
,	NULL
and	NULL
DV	NULL
.	NULL

Faller	NULL
.	NULL

1987	NULL
.	NULL

Interleukin	NULL
1	NULL
induces	NULL
cultured	NULL
human	NULL
endothelial	NULL
cell	NULL
production	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79:48	NULL
.	NULL

Broudy	NULL
,	NULL
V.C	NULL
.	NULL

,	NULL
K.	NULL
Kaushansky	NULL
,	NULL
G.M	NULL
.	NULL

Segal	NULL
,	NULL
and	NULL
JW	NULL
.	NULL

Adamson	NULL
.	NULL

1986	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
type	NULL
alpha	NULL
stimulates	NULL
human	NULL
endothelial	NULL
cells	NULL
to	NULL
produce	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

83:7467	NULL
.	NULL

Thompson	NULL
,	NULL
C.B	NULL
.	NULL

,	NULL
T.	NULL
Lindsten	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
S.L	NULL
.	NULL

Kunkel	NULL
,	NULL
H.A	NULL
.	NULL

Young	NULL
,	NULL
S.G.	NULL
Emerson	NULL
,	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
and	NULL
C.H	NULL
.	NULL

June	NULL
.	NULL

1989	NULL
.	NULL

CD28	NULL
activation	NULL
pathway	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
T-cell-derived	NULL
lymphokines/cytokines	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:1333	NULL
.	NULL

Fung	NULL
,	NULL
MC	NULL
.	NULL

,	NULL
A.J	NULL
.	NULL

Hapel	NULL
,	NULL
S.	NULL
Ymer	NULL
,	NULL
D.R	NULL
.	NULL

Cohen	NULL
,	NULL
R.M	NULL
.	NULL

Johnson	NULL
,	NULL
H.D	NULL
.	NULL

Campbell	NULL
,	NULL
and	NULL
L.G	NULL
.	NULL

Young	NULL
.	NULL

1984	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
cDNA	NULL
from	NULL
murine	NULL
interleukin-3	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

307:233	NULL
.	NULL

Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
A.B	NULL
.	NULL

Ciarletta	NULL
,	NULL
P.A	NULL
.	NULL

Temple	NULL
,	NULL
M.P	NULL
.	NULL

Chung	NULL
,	NULL
S.	NULL
Ko-vacic	NULL
,	NULL
J.S	NULL
.	NULL

Witek-Giannotti	NULL
,	NULL
A.C.	NULL
Leary	NULL
,	NULL
R.	NULL
Kriz	NULL
,	NULL
RE	NULL
.	NULL

Donahue	NULL
,	NULL
G.G	NULL
.	NULL

Wong	NULL
,	NULL
and	NULL
S.	NULL
Clark	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
IL-3	NULL
(	NULL
multi-CSF	NULL
)	NULL
:	NULL
identification	NULL
by	NULL
expression	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
related	NULL
to	NULL
murine	NULL
IL-3	NULL
.	NULL

Cell	NULL
.	NULL

47:3	NULL
.	NULL

Ryan	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
S.E	NULL
.	NULL

Milton	NULL
,	NULL
A.F	NULL
.	NULL

Lopez	NULL
,	NULL
PG	NULL
.	NULL

Bardy	NULL
,	NULL
M.A	NULL
.	NULL

Vadas	NULL
,	NULL
and	NULL
M.F	NULL
.	NULL

Shannon	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
Interleukin-3	NULL
mRNA	NULL
accumulation	NULL
is	NULL
controlled	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
level	NULL
.	NULL

Blood	NULL
.	NULL

77:1195	NULL
.	NULL

Dokter	NULL
,	NULL
W.H.A	NULL
.	NULL

,	NULL
MT	NULL
.	NULL

Esselink	NULL
,	NULL
S.J	NULL
.	NULL

Sierdsema	NULL
,	NULL
M.R	NULL
.	NULL

Halie	NULL
,	NULL
and	NULL
E.	NULL
Vellenga	NULL
.	NULL

1993	NULL
.	NULL

Transcriptional	NULL
and	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
the	NULL
Interleukin-4	NULL
and	NULL
Interleukin-3	NULL
genes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

81:35	NULL
.	NULL

Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
N.C.	NULL
Andrews	NULL
,	NULL
H.S	NULL
.	NULL

Murphy	NULL
,	NULL
SG	NULL
.	NULL

Kreissman	NULL
,	NULL
and	NULL
D.G	NULL
.	NULL

Nathan	NULL
.	NULL

1990	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
elements	NULL
regulate	NULL
human	NULL
Interleukin	NULL
3	NULL
expression	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:5046	NULL
.	NULL

Shoemaker	NULL
,	NULL
S.G.	NULL
,	NULL
R.	NULL
Hromas	NULL
,	NULL
and	NULL
K.	NULL
Kaushansky	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
interleukin	NULL
3	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9650	NULL
.	NULL

Davies	NULL
,	NULL
K.	NULL
,	NULL
E.C	NULL
.	NULL

TePas	NULL
,	NULL
D.G	NULL
.	NULL

Nathan	NULL
,	NULL
and	NULL
B.	NULL
Mathey-Prevot	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-3	NULL
expression	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
involves	NULL
an	NULL
inducible	NULL
,	NULL
T	NULL
cell-specific	NULL
factor	NULL
and	NULL
an	NULL
octamer	NULL
binding	NULL
pro-tein	NULL
.	NULL

Blood	NULL
.	NULL

81:928	NULL
.	NULL

Shannon	NULL
,	NULL
MF	NULL
.	NULL

,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Vadas	NULL
.	NULL

1988	NULL
.	NULL

Nuclear	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:674	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Takaoka	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
and	NULL
T.	NULL
Taniguichi	NULL
.	NULL

1983	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:7437	NULL
.	NULL

Emmel	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
C.L	NULL
.	NULL

Verweij	NULL
,	NULL
D.B	NULL
.	NULL

Durand	NULL
,	NULL
K.M	NULL
.	NULL

Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

246:1617	NULL
.	NULL

Montiminy	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
K.	NULL
A.	NULL
Sevarino	NULL
,	NULL
J.A	NULL
.	NULL

Wagner	NULL
,	NULL
G.	NULL
Mandel	NULL
,	NULL
1691	NULL
Gottschalk	NULL
et	NULL
al	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42.	NULL
and	NULL
R.H.	NULL
Goodman	NULL
.	NULL

1986	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
cyclic-AMP-responsive	NULL
element	NULL
within	NULL
the	NULL
rat	NULL
somatostatin	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

83:6682	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
c-ets	NULL
proto-oncogenes	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

346:191	NULL
.	NULL

Boise	NULL
,	NULL
LH	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.H	NULL
.	NULL

June	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.L	NULL
.	NULL

Leiden	NULL
,	NULL
and	NULL
C.B	NULL
.	NULL

Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
R.J.	NULL
Imbra	NULL
,	NULL
H.J	NULL
.	NULL

Rahmsdorf	NULL
,	NULL
C.	NULL
Jonat	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Phorbol	NULL
ester-inducible	NULL
genes	NULL
contains	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
trans-acting	NULL
factor	NULL
.	NULL

Cell	NULL
.	NULL

49:729	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tijan	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
ele-ments	NULL
.	NULL

Cell	NULL
.	NULL

49:741	NULL
.	NULL

Ransone	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
and	NULL
I.M	NULL
.	NULL

Verma	NULL
.	NULL

1990	NULL
.	NULL

Nuclear	NULL
proto-oncogenes	NULL
fos	NULL
and	NULL
jun	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:539	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Labora-tory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1982	NULL
.	NULL

A	NULL
technique	NULL
for	NULL
radi-olabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:6	NULL
.	NULL

Gottschalk	NULL
,	NULL
LR	NULL
.	NULL

,	NULL
and	NULL
J.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
3	NULL
gene	NULL
transcriptional	NULL
enhancer	NULL
:	NULL
common	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
x	NULL
and	NULL
(	NULL
3	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5486.	NULL
deWet	NULL
,	NULL
J.R.	NULL
,	NULL
KV	NULL
.	NULL

Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.R	NULL
.	NULL

Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
A.R	NULL
.	NULL

Coulson	NULL
.	NULL

1977	NULL
.	NULL

DNA	NULL
sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

12:5463	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-kappa	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

333:776	NULL
.	NULL

Boulukos	NULL
,	NULL
K.E	NULL
.	NULL

,	NULL
P.	NULL
Pognonec	NULL
,	NULL
B.	NULL
Rabault	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
and	NULL
R.	NULL
Ghysdael	NULL
.	NULL

1989	NULL
.	NULL

Definition	NULL
of	NULL
an	NULL
Ets1	NULL
protein	NULL
domain	NULL
required	NULL
for	NULL
nuclear	NULL
localization	NULL
in	NULL
cells	NULL
and	NULL
DNA-binding	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

1989	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5719	NULL
.	NULL

Gunther	NULL
,	NULL
CV	NULL
.	NULL

,	NULL
J.A	NULL
.	NULL

Nye	NULL
,	NULL
R.S	NULL
.	NULL

Bryner	NULL
,	NULL
and	NULL
BJ	NULL
.	NULL

Graves	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
ets-1	NULL
defines	NULL
a	NULL
Molony	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Gene	NULL
&	NULL
Dev	NULL
.	NULL

4:667	NULL
.	NULL

Karim	NULL
,	NULL
FD	NULL
.	NULL

,	NULL
L.D	NULL
.	NULL

Urness	NULL
,	NULL
C.S	NULL
.	NULL

Thummael	NULL
,	NULL
M.J.	NULL
Klemsz	NULL
,	NULL
S.R	NULL
.	NULL

MeKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
R.A.	NULL
Maki	NULL
,	NULL
CV	NULL
.	NULL

Gunther	NULL
,	NULL
J.A	NULL
.	NULL

Nye	NULL
,	NULL
and	NULL
B.J	NULL
.	NULL

Graves	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA	NULL
binding	NULL
motif	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

4:1451	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
NK	NULL
.	NULL

Bhat	NULL
,	NULL
LR	NULL
.	NULL

Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.B	NULL
.	NULL

Thompson	NULL
,	NULL
T.S	NULL
.	NULL

Papis	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
Ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
&	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

250:814-818	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
C.B	NULL
.	NULL

Thompson	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
J.	NULL
Exp	NULL
Med	NULL
.	NULL

175:1391	NULL
.	NULL

Fraser	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
B.A	NULL
.	NULL

Irving	NULL
,	NULL
G.R	NULL
.	NULL

Crabtree	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

251:313	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
P.	NULL
Vorhees	NULL
,	NULL
N.	NULL
Marin	NULL
,	NULL
BK	NULL
.	NULL

Oakley	NULL
,	NULL
S.-F.	NULL
Tsai	NULL
,	NULL
S.H	NULL
.	NULL

Orkin	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
GATA-3	NULL
:	NULL
a	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
&	NULL
gene	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

10:1187	NULL
.	NULL

Thompson	NULL
,	NULL
C.B	NULL
.	NULL

,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
P.J	NULL
.	NULL

Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.H	NULL
.	NULL

June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.J	NULL
.	NULL

Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
.	NULL

1992	NULL
.	NULL

Cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
ets-related	NULL
protein	NULL
,	NULL
Elf1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Lanahan	NULL
,	NULL
E.	NULL
Perez-Albuerne	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1989	NULL
.	NULL

Jun-D	NULL
:	NULL
a	NULL
third	NULL
member	NULL
of	NULL
the	NULL
Jun	NULL
gene	NULL
family	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:1500	NULL
.	NULL

Hirai	NULL
,	NULL
S.-I	NULL
.	NULL

,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
F.	NULL
Mechta	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
M.	NULL
Yaniv	NULL
.	NULL

1989	NULL
.	NULL

Characterization	NULL
of	NULL
junD	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
jun	NULL
protooncogene	NULL
family	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

8:1433	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1240-1250	NULL
.	NULL

Gutman	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
collagenase	NULL
gene	NULL
promoter	NULL
contains	NULL
a	NULL
TPA	NULL
and	NULL
oncogene-responsive	NULL
unit	NULL
encompassing	NULL
the	NULL
PEA3	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:2241	NULL
.	NULL

Markovitz	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
M.	NULL
Hannibal	NULL
,	NULL
V.L	NULL
.	NULL

Perez	NULL
,	NULL
C.	NULL
Gauntt	NULL
,	NULL
TW	NULL
.	NULL

Folks	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Nabel	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
human	NULL
1692	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54.	NULL
immunodeficiency	NULL
viruses	NULL
(	NULL
HIVs	NULL
)	NULL
:	NULL
a	NULL
specific	NULL
regulatory	NULL
element	NULL
in	NULL
HIV-2	NULL
responds	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9098	NULL
.	NULL

Bosselut	NULL
,	NULL
R.	NULL
,	NULL
J.F	NULL
.	NULL

Duvall	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
A.	NULL
Hemat	NULL
,	NULL
J.	NULL
Brady	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
c-ets-1	NULL
proto-oncogene	NULL
and	NULL
the	NULL
related	NULL
Ets2	NULL
protein	NULL
act	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
HTLV-1	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:3137	NULL
.	NULL

Schwartz	NULL
,	NULL
R.H.	NULL
1990	NULL
.	NULL

A	NULL
cell	NULL
culture	NULL
model	NULL
for	NULL
T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

248:1344	NULL
.	NULL

Kong	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
B.	NULL
Beverly	NULL
,	NULL
A.C.	NULL
Tran	NULL
,	NULL
K.	NULL
Bronson	NULL
,	NULL
R.H.	NULL
Schwartz	NULL
,	NULL
and	NULL
M.J.	NULL
Leonardo	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
by	NULL
AP-1	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
of	NULL
T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

257:1134	NULL
.	NULL

Rozans	NULL
,	NULL
MK	NULL
.	NULL

,	NULL
BR	NULL
.	NULL

Smith	NULL
,	NULL
S.J	NULL
.	NULL

Burakoff	NULL
,	NULL
and	NULL
R.A.	NULL
Miller	NULL
.	NULL

1986	NULL
.	NULL

Long-lasting	NULL
deficit	NULL
of	NULL
functional	NULL
T	NULL
cell	NULL
precursors	NULL
in	NULL
human	NULL
bone	NULL
marrow	NULL
transplant	NULL
recipients	NULL
revealed	NULL
by	NULL
limiting	NULL
dilution	NULL
methods	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

136:4040	NULL
.	NULL

Thomas	NULL
,	NULL
S.	NULL
,	NULL
S.C.	NULL
Clark	NULL
,	NULL
J.M	NULL
.	NULL

Rappaport	NULL
,	NULL
D.G	NULL
.	NULL

Nathan	NULL
,	NULL
and	NULL
$	NULL
.G	NULL
.	NULL

Emerson	NULL
.	NULL

1990	NULL
.	NULL

Deficient	NULL
T	NULL
cell	NULL
GM-CSF	NULL
production	NULL
in	NULL
allogeneic	NULL
bone	NULL
marrow	NULL
transplant	NULL
recipients	NULL
.	NULL

Transplantation	NULL
(	NULL
Baltimore	NULL
)	NULL
.	NULL

49:703	NULL
.	NULL

Molecular	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
IL-3	NULL
Gene	NULL

